first announcement - CIRSE.org

Cardiovascular and Interventional Radiological Society of Europe 

Rome, Italy 

September 9-13 

CIRSE 2006 

FIRST 

ANNOUNCEMENT 

MAIN 

PROGRAMME 

AND 

ABSTRACT BOOK 

C RSE

Rome 2006 

5 

7 

8 

9 

10 

12 

13 

15 

18 

19 

20 

21 

23 

24 

25 

27 

29 

30 

31 

32 

34 

81 

Content 

Content 

Welcome Addresses 

CIRSE Committees 

Awards and Honours 

Gold Medal 

Distinguished Fellowships 

Gruentzig Lecture 

Roesch Lecture 

General Information 

Become a CIRSE Member 

IR News 

Rome, the Eternal City 

The CIRSE Website 

Session Types 

Workshops 

Technical Exhibition 

Boston Scientific Symposia 

Good Clinical Research Awareness Programme 

Social and Cultural Programme 

Opening Ceremony and Concert 

Programme Overview 

Scientific Programme 

Abstracts 

Editor: Michael Lee, Dublin, Ireland 

Editorial Office: 

CIRSE, Vienna, Austria 

Online publication number: 

10.1007/s00270-006-7291-3 

CIRSE does not accept responsibility for errors or misprints 

C RSE 

3

Rome 2006 

Dear Colleagues, 

Welcome to the CIRSE 2006 Annual Meeting 

and Postgraduate Course, the most 

advanced scientific and educational event 

organized in the field of Cardiovascular and 

Interventional Radiology in Europe. 

This year's meeting will offer you the possibility 

to select from 29 special sessions, 45 workshops, 

more than 130 lectures, 3 interactive 

case discussions, 160 free papers, 264 scientific 

exhibits, 18 satellite symposia and the largest 

dedicated technical exhibition, among many 

other things. 

The programme will enhance one's own theoretical 

knowledge on the main diagnostic and 

therapeutic procedures and provide the 

chance to practice specific parts of 

Interventional Radiology that are of remarkable 

clinical importance. 

Apart from CIRSE's outstanding congress, 

Rome, "la città eterna", will offer all participants 

its beauties for which it is very well 

known worldwide: its monuments, historical 

sites going back thousands of years, its 

churches, buildings and much more. It will 

also offer its residents' welcome to you, the 

vital atmosphere of the old city centre and its 

typical restaurants. 

Welcome to CIRSE 2006, welcome to Rome! 

Roberto Passariello 

Meeting Chairman 

Giovanni Simonetti 

Meeting Co-Chairman 

C RSE 

Welcome Addresses 

Welcome to the Eternal City, where Julius 

Ceasar, Augustus, Nerva and Trajan walked 

in antiquity. CIRSE now follows in their 

footsteps by bringing the Annual Meeting 

to Rome. 

For those of you who enjoy a sense of history, 

this is probably one of the most historic cities 

in the world, and to walk through the Forum, 

the Coliseum or the Capitoline and Palatine 

Hills is to walk back in time. I hope you will 

find time during your visit in Rome to enjoy 

these historic delights, as well as the friendly 

atmosphere, beautiful architecture and restaurants 

of the new Rome. 

There is a very exciting programme at the 

CIRSE meeting this year, with numerous basic 

and advanced workshops, foundation courses 

on biliary intervention and SFA angioplasty, a 

mini-symposium on intermittent claudication 

running over three days, multiple satellite 

symposia, hands-on workshops and exposure 

to simulation machines for Interventional 

Radiology. Truly, there is something for everyone 

at this CIRSE meeting. 

The social functions organised by Professor 

Passariello and Professor Simonetti will be 

spectacular and I thank them for all their 

efforts. 

I look forward to seeing you in Rome for what 

promises to be an excellent educational, professional 

and social meeting. 

Michael Lee 

Chairman - Scientific Programme Committee 

5

Rome 2006 


Executive Committee 

President 

J. Lammer (Vienna/AT) 

Vice President 

J. Reekers (Amsterdam/NL) 

Treasurer 

J. Peregrin (Prague/CZ) 

Foundation Advisory Council Chair 

A. Adam (London/UK) 

Scientific Programme Committee Chair 

M. Lee (Dublin/IE) 

Scientific Programme Committee Deputy 

M. Sapoval (Paris/FR) 

Standards of Practice Committee Chair 

R. Lencioni (Pisa/IT) 

Membership Committee Chair 

A. Hatzidakis (Heraklion/GR) 

Communication Officer 

E.-P. Strecker (Karlsruhe/DE) 

Rules Committee Chair 

M. Szczerbo-Trojanowska (Lublin/PL) 

Meeting Chair 

R. Passariello (Rome/IT) 

EU Officer 

L. Johnston (Belfast/UK) 

Editor of the Society Journal 

D. Vorwerk (Ingolstadt/DE) 

Member 

J.I. Bilbao (Pamplona/ES) 

Executive Director 

D. Waigl (Vienna/AT) 

C RSE 


Scientific Programme Committee 

M. Lee (Dublin/IE), Chair 

M. Sapoval (Paris/FR), Deputy 

M. Bezzi (Rome/IT) 

E. Brountzos (Athens/GR) 

J. Lammer (Vienna/AT) 

R. Lencioni (Pisa/IT) 

A. Nicholson (Leeds/UK) 

A. Watkinson (Exter/UK) 

Local Organising Committee 

P. Rossi (Rome), Honorary Chair 

R. Passariello (Rome), Meeting Chair 

G. Simonetti (Rome), Meeting Co-Chair 

C. Bartolozzi (Pisa) 

M. Bezzi (Rome) 

L. Bonomo (Rome) 

G. Cornalba (Milan) 

G. Ettorre (Catania) 

G. Feltrin (Vicenza) 

G. Gandini (Torino) 

R. Gandini (Rome) 

V. Iaccarino (Naples) 

L. Lupattelli (Perugia) 

F. Maglione (Naples) 

G. Mallarini (Cagliari) 

F. Salvatori (Rome) 

Membership Committee 

A. Hatzidakis (Heraklion/GR), Chair 

D. Apitzsch (Marl/DE) 

P. Bosnjakovic (Nis/CS) 

T. Jahnke (Kiel/DE) 

M. Schoder (Vienna/AT) 

Rules Committee 

M. Szczerbo-Trojanowska (Lublin/PL), Chair 

K. Hausegger (Klagenfurt/AT) 

A. Kelekis (Athens/GR) 

T. Sabharwal (Bromley/UK) 

K. Schürmann (Dortmund/DE) 

Standards of Practice Committee 

R. Lencioni (Pisa/IT), Chair 

T. de Baere (Villejuif/FR) 

D. Tsetis (Heraklion/GR) 

R. Uberoi (Oxford/UK) 

J. Wildberger (Aachen/DE) 

7

8 Awards and Honours 

CIRSE Gold Medallists 

2006 B.T. Katzen 

2005 J.F. Reidy 

2004 J. Struyven 

2003 Ch. L. Zollikofer 

2002 J. Göthlin, J.-J. Merland, E. Zeitler 

2001 E. Boijsen, F. Olbert, F. Pinet 

2000 P. Rossi 

1999 A. Lunderquist 

1998 D.J. Allison 

1997 R.W. Günther 

CIRSE Distinguished Fellows 

2006 A. Rosenberger, G. Simonetti 

2005 F.S. Keller, A.J. Roche 

2004 B. Läubli, R. Yamada, P. Mueller, A. Besim 

2003 K. Hiramatsu, F. Joffre, H. Uchida 

2002 Cl. L'Herminé, J.-M. Rius, M.R. Dean 

2001 J.M. Bigot, J. Edgren 

2000 J.C. Gaux, L. Horváth 

1999 U. Tylén 

1998 A. Essinger 

1997 J.H. Göthlin, J. Struyven 

1996 M. Amiel, P. Rossi 

1995 U. Erikson 

1994 D.J. Allison 

1993 E. Zeitler 

1992 I. Enge, A. Lunderquist, F. Olbert 

1991 A. Pinet, F. Pinet 

1990 A. Baert, L. Di Guglielmo, G. Van Andel 

1989 J.-L. Lamarque, R. Passariello 

1988 E. Boijsen, C. Puylaert, E. Voegeli 

Annual Meeting and Postgraduate Course 


2006 L. Solbiati 

2005 A.C. Roberts 

2004 E.-P. Strecker 

2003 K.R. Thomson 

2002 P.A. Gaines 

2001 B.T. Katzen 

2000 J. Struyven 

1999 S. Wallace 

1998 R.W. Günther 

1997 P. Rossi 

1996 J. Rösch 


2006 L. Machan 

2005 H.P. Rousseau 

2004 F. Keller 

2003 J. Rösch

Rome 2006 

Gold Medallist 

Barry T. Katzen 

Barry T. Katzen is the founder and Medical 

Director of Baptist Cardiac & Vascular Institute, 

a part of Baptist Health South Florida and is a 

clinical Professor of Radiology at the 

University of Miami School of Medicine. 

Dr. Katzen, who is a resident of Coral Gables, 

Florida, is married to Judith and has three 

daughters. He graduated from the University 

of Miami School of Medicine and was honored 

with the gold medal of its alumni association. 

He entered into the "Hall of Fame" at the 

Medical School, only the fourth such honoree 

in medical school history. Dr. Katzen completed 

an internship at Jackson Memorial Hospital 

and a radiology residency at the New York 

Hospital Cornell Medical Center. He was 

awarded a fellowship in cardiovascular radiology 

at St. Vincent's Hospital and Medical 

Center in New York. 

Dr. Katzen considers himself to be "European 

trained", since his fellowship time was spent at 

the Policlinico Umberto Primo "La Sapienza" 

(University of Rome) under the direction of 

Plinio Rossi, M.D. After returning to the United 

States, he became Director of Cardiovascular 

Radiology at St. Vincent's Hospital Medical 

Center in New York. During that time, he 

established the use of angioplasty and thrombolysis 

through a collaborative relationship 

with vascular surgery. 

In 1976 Dr. Katzen established the Non- 

Invasive Vascular Laboratory and 

Interventional Radiology Programs at 

Alexandria Hospital in Virginia. During his time 

in Alexandria, he pioneered the use of video 

and sophisticated audiovisual technology to 

enhance the process of education for established 

practitioners. He is credited with being 

the first to use "live patient demonstrations" in 

the United States, which went on to become 

the benchmark for procedural education in 

endovascular therapy. 

In 1987 Dr. Katzen moved to Miami, Florida, to 

found what was then called Miami Vascular 

Institute at Baptist Hospital. The successful 

development of a unique multidisciplinary 

infrastructure resulted in Baptist Hospital 

developing a $20 million dollar free-standing 

facility attached to the main hospital. Two 

additional floors, including a 40,000 square 

foot patient care center, were added in 2000 

to complete the Institutes' vision to have all 

services totally integrated. 

Dr. Katzen is the Founding Medical Director 

and Chairman of Baptist Cardiac & Vascular 

C RSE 

Gold Medal 

Institute's Executive Committee and serves in 

numerous capacities throughout Baptist 

Health of South Florida, including being a 

Board Member of the Baptist Hospital 

Foundation. 

Since its foundation nearly 20 years ago, the 

Institute has gone through numerous 

changes, resulting in its ultimate name, Baptist 

Cardiac & Vascular Institute. It has served as a 

national model of the success of multidisciplinary 

cooperation leading to hundreds of site 

visits from institutions from around the country. 

Dr. Katzen has authored numerous book chapters, 

in addition to over 160 peer reviewed 

articles in scientific journals. He is considered 

one of the pioneers of percutaneous transluminal 

angioplasty and peripheral thrombolysis 

for less invasive treatment of vascular disease 

and was part of the investigative team that 

lead to the approval of the first intravascular 

stent. More recently, he has been actively 

involved with the development of endovascular 

repair of AAA and carotid stenting. 

Dr. Katzen is the founding editor of Techniques 

in Vascular and Interventional Radiology and is 

currently one of the Chief Medical Editors of 

Endovascular Today. Dr. Katzen has been 

national site principal investigator for many 

clinical trials in AAA and other aneurysms, 

carotid stents and other medical devices. He 

has given invited and named lectures 

throughout the world and additionally has 

worked hard to assist the development of 

innovative procedures in various countries 

including Singapore, Thailand, Japan and 

Korea. 

Together with his colleagues, Dr. Katzen also 

created the Endovascular Forum, one of the 

first interactive circulatory disease websites for 

physicians. On two occasions he has been chosen 

as one of Radiology's 20 Most Influential 

by Diagnostic Imaging magazine, in addition 

to being listed in Best Doctors in America. 

Dr. Katzen has been passionate about transforming 

Interventional Radiology from a technical 

to a clinical discipline through his writings 

and teaching. His brand of clinical practice 

has been emulated by many others 

throughout the United States and Europe. He 

is a past president of the Society of 

Interventional Radiology and was part of its 

Executive Committee for many years. Dr. 

Katzen has been awarded the Society of 

Interventional Radiology's Gold Medal for lifetime 

achievement. He has also served as 

Chairman of the American Heart Association's 

Council of Cardiovascular Radiology and 

Intervention. 

9

10 Distinguished Fellowship 

Distinguished Fellow 

Alex Rosenberger 

Professor Alex Rosenberger was born in Novi 

Sad, Yugoslavia, in 1927. 

He survived the Second World War and the 

concentration camps as a youth. In 1954, he 

graduated from the Hadassah Hospital and 

Hebrew University Medical School in 

Jerusalem. 

For 22 years he headed the Department of 

Radiology at Rambam Medical Center in Haifa 

and taught as a Professor of Radiology at the 

Faculty of Medicine of the Technion - Israel 

Institute of Technology, Haifa. 

Professor Rosenberger received his angiographic 

training in 1966/7 at Stanford 

University School of Medicine under the 

tuition of Professor Herbert L. Abrams, which 

was the beginning of his many international 

professional and personal ties with America 

and Europe. His friends in the field include 

Professors Paulin, Baum, Wallace, Bojsen, 

Fuchs, Voegeli, Zeitler, Dondelinger and many 

others. 

Professor Rosenberger established the 

Angiographic /Interventional Service at 

Rambam and is one of the founders of 

Angiography and Interventional Radiology in 

his country. For more than 20 years he was the 

president of the Israel Radiological Society. He 

is a member of numerous national and international 

societies, among them the European 

Radiological Society, the European College of 

Angiography and, of course, CIRSE. 



Professor Rosenberger is one of the founding 

members of CIRSE and was its president, as 

well as the president of its congress in 

Jerusalem in 1986. His clinical and research 

work includes the landmark work on the thoracic 

duct and pioneering work of aspiration 

biopsies of the mediastinum. In addition to his 

angiographic and interventional work, he 

understood the importance of CT in trauma 

from a very early stage. He coauthored two 

books on this topic and coauthored and edited 

an Acta Supplement on combat trauma. 

Professor Rosenberger has authored and presented 

numerous papers and lectures in 

national and international meetings and 

forums. He has been a member of the editorial 

board of two major cardiovascular/ interventional 

imaging journals, namely 

Cardiovascular Radiology (Springer) and 

Cardiovascular and Interventional Radiology 

(USA). 

Professor Rosenberger is retired now, but continues 

his clinical work and post graduate 

teaching.

Rome 2006 

Distinguished Fellow 

Giovanni Simonetti 

Giovanni Simonetti, born in Oristano, Sardinia, 

on November 12th, 1944, enrolled in the 

School of Medicine and Surgery of the 

University of Sassari, where he graduated with 

full marks in 1969/1970. From 1970 to 1971 he 

was a voluntary assistant at the Institute of 

Medical Pathology of the University of Sassari, 

directed by Prof. Giovanni Pende. In 1972 he 

specialized in Medical Radiology at the 

University of Cagliari. In his cum laude thesis 

he discussed angiography in renal traumatisms. 

In 1972, Prof. Simonetti started working at the 

Institute of Radiology of the University of 

Rome "La Sapienza", where he became a regular 

assistant and assistant professor in 1982. In 

December 1982, he was appointed Associate 

Professor of Radiology at the School of 

Medicine and Surgery of the University of 

Sassari. In 1983 Prof. Simonetti was appointed 

Chairman of the Institute of Radiological 

Sciences and Director of the School of 

Radiological Diagnosis and Cancer 

Radiotherapy of the University of Sassari. In 

1984 he was appointed Extraordinary 

Professor with the same tasks at the University 

of Sassari. 

Since 1990 Prof. Simonetti has been a 

Professor of Radiology and the Director of the 

Faculty of Radiology at the School of Medicine 

and Surgery of the University of Rome Tor 

Vergata. He is one of the 6 members of the 

Clinicians' Council in charge of the organization 

of the University of Rome Tor Vergata 

Policlinico. 

From 2003 to 2005, he served as an expert for 

high technologies at the Higher Institute of 

Health and a member of the Scientific 

Committee of the same institute. Prof. 

Simonetti's rich scientific output includes 

more than 575 publications, of which 211 

were published in international journals. 

Besides his numerous publications, Prof. 

Simonetti is also the author of a large number 

of books, including Novelties in the treatment 

of arterial diseases, Trattato Italiano di 

Risonanza Magnetica and many more. 

Throughout his career he has participated in 

more than 1,000 national and international 

meetings as a speaker, moderator, organizer 

and president. Prof. Simonetti is a member of 

C RSE 

Distinguished Fellowship 

the editorial board of several national and 

international journals. His scientific and 

research interests focus on imaging, especially 

on cardio-vascular radiology, interventional 

radiology and diagnostic senology. Prof. 

Simonetti is an active member of numerous 

Italian and international medical associations, 

including the Italian Society of Medical 

Radiology, the Italian Society of Surgery, the 

EAR, the EUROSBI and, of course, CIRSE. 

In order to increase his experience, enrich his 

cultural background and learn new techniques, 

Prof. Simonetti has spent long periods 

of time in highly qualified Centres in the USA 

and Europe for studies and research purposes, 

including the Cleveland Clinic, Mount Sinai 

Hospital in Miami, the University of Portland, 

Oregon, Lund University in Sweden, the 

International Institute of Health Disease in 

Tokyo and many more. 

Prof. Simonetti was the first doctor in Italy to 

perform the embolization of a digestive haemorrhage 

(1971) and a PTA on a stenosis of the 

iliac artery (1973). In 1976 Prof. Giovanni 

Simonetti, together with Prof. Plinio Rossi, Prof. 

Roberto Passariello and 16 other colleagues 

from several European countries founded the 

AER in Lund. 

In 1975 Prof. Simonetti was appointed 

Secretary of the European Cardiovascular 

Society. From 1983 to 1987, he served as 

President of the Italian Section of Vascular and 

Interventional Radiology. In 1987, he organized 

a meeting of CIRSE in Porto Cervo. Since 

1988 he has organised a yearly Campus of 

Interventional Radiology for young radiologists. 

Furthermore he is the organiser of the 

International Course on Endovascular 

Procedures (ICEP), which is held every year 

with more than 500 participants and constitutes 

one of the most important courses on 

Interventional Radiology in Italy. 

Prof. Simonetti is actively engaged as an 

angiographer in routine health care, diagnosis 

and interventional activities. He can certainly 

be called the most active interventional radiologist 

in Italy, regarding health care as well as 

education and politics. 

11

12 Gruentzig Lecture 


Luigi Solbiati 

Luigi Solbiati was born in the city of Busto 

Arsizio, Italy, in 1952. In 1977 he received his 

medical degree from the University of Milan, 

where he went on to study Radiology at the 

National Cancer Institute. His postgraduate 

education was completed through study visits 

to the Department of Ultrasound at the Royal 

Marsden Hospital in Sutton, UK and the 

Department of Medical Physics at Bristol 

Hospital, UK. 

Prof. Solbiati started his career at the 

Department of Radiology of Busto Arsizio 

General Hospital, where he was a Radiology 

assistant from 1980 to 1989 and assistant 

chairman from 1989 to 1999. Starting in 1999, 

he headed the Department of Ultrasound and 

Interventional Radiology. In 2002 he was 

appointed chairman of the Hospital's 

Diagnostic Imaging Department. 

Since 1988 he has been contract Professor of 

Techniques and Methods of Diagnostic 

Imaging at the School of Radiology of the 

University of Milan. 

In the 25 years of his professional career, Prof. 

Solbiati has published 229 papers in peerreviewed 

journals, 84 of which appeared in 

international journals. Furthermore, he edited 

three international books and 7 books on 

ultrasound published in Italy. His books 

"Contrast-enhanced sonography of liver diseases" 

(Springer, 2003) and "Tumour ablation" 

(Springer, 2005) were the first books published 

on the clinical use of second generation ultra- 

C RSE 


sound contrast agents and image-guided 

tumour ablation, respectively. Currently he is a 

member of the editorial boards of the 

European Journal of Ultrasound and the 

Journal of Clinical Ultrasound and serves as a 

reviewer for Radiology, the Journal of 

Hepatology and the Journal for Cardiovascular 

and Interventional Radiology. 

Prof. Solbiati has been invited as a speaker to 

341 courses and congresses, among them 129 

international meetings. He has been invited as 

a guest lecturer by the University of California, 

San Diego, the Mayo Clinic, Rochester, USA, as 

well as the Universities of Zurich, Beijing, New 

Delhi, Cairo and Vienna. His main fields of 

interest are small parts ultrasound, interventional 

procedures in oncologic diseases (particularly 

tumour ablation), the anatomy and 

pathology of the neck and ultrasound contrast 

agents. His papers on topics like aspiration 

biopsies of the liver, adrenal glands, spleen 

and parathyroid glands, sonography of thyroid 

nodules, ethanol injection of parathyroid 

tumours and radiofrequency ablation of liver 

metastases were among the first published in 

medical literature. 

In June 2004 Prof. Solbiati was elected 

President of the Section of Ultrasound of the 

Italian Society of Radiology. Prof. Solbiati also 

chaired the first World Conference on 

Interventional Oncology, which took place in 

Italy in June 2006.

Rome 2006 


Lindsay Machan 

Lindsay Machan was born in Edmonton, 

Canada in 1955. He received his BMSc and his 

MD in 1979 from the University of Alberta. 

From 1979 to 1981 he was a house surgeon 

and registrar in pediatrics at the University of 

Otago, Dunedin, New Zealand, and from 1982 

to 1983 a registrar in pediatrics at the Royal 

Children's Hospital in Melbourne, Australia . 

Between 1983 and 1986 he did his residency 

in radiology at the University of British 

Columbia in Vancouver, British Columbia, followed 

by a fellowship in Interventional 

Radiology from 1986 to 1987 under Joachim 

Burhenne at the same institution. Further tutelage 

in Interventional Radiology came in 1987 

and 1988 as a locum consultant with Professor 

David Allison and Andy Adam at the 

Hammersmith Hospital in London, and in 1989 

as a visiting assistant professor at the 

University of Pennsylvania with Stan Cope. 

Dr. Machan is a clinical radiologist involved in 

imaging and Interventional Radiology. He has 

been an advocate for supervising patient care 

and taking an active role in the decision-making 

process. His primary clinical interests are 

gynecological interventions, interventions in 

infertility, venous embolization and stent 

grafts. He has performed multiple first-in-man 

procedures including the first drug eluting 

stent implantation in 1996, and the first drug 

eluting vascular stent in 1999. He has an active 

research laboratory investigating primarily the 

application of drugs to devices. 


He has delivered over 470 lectures at medical 

meetings including 6 eponymous lectures, 

authored and co-authored 85 scientific articles 

and chapters and is the inventor or co-inventor 

of 6 patents. He is a founding member and 

member of the executive of the Canadian 

Interventional Radiology Association and has 

served as president of the Western 

Angiographic and Interventional Society. 

Dr. Machan is on one editorial board and is a 

reviewer for 3 medical journals journals. He 

has served on multiple committees and expert 

consensus groups for the Society of 

Interventional Radiology, the American Heart 

Association and the British Columbia Ministry 

of Health. He is passionate about science education 

and its agonal condition in primary and 

secondary education. To this end he is on 

committees for BC Science World and BC 

Social Venture Partners. 

Dr. Machan is an Associate Professor of 

Radiology and former Head of Angiography 

and Interventional Radiology at Vancouver 

Hospital. In 1992 he co-founded Angiotech 

Pharmaceuticals Inc., a biomedical company 

which has commercialized paclitaxel coated 

stents, among other products. He continues as 

a consultant to that company as well as on the 

scientific advisory board of multiple other 

medical device companies. 


13

Rome 2006 


Online Pre-Registration 

Pre-registration on our website www.cirse.org 

will be accepted until August 20 th , 2006. If you 

would like to register after August 20 th , please 

do so at the registration desk at the Palazzo 

dei Congressi (please refer to opening hours 

below). 

Onsite Registration 

The registration desks are located next to the 

main entrance in the foyer of the conference 

centre. 

Onsite Registration Desk Opening Hours 

Friday, September 8 16.00 - 18.00 

Saturday, September 9 07.00 - 18.00 

Sunday, September 10 07.30 - 18.00 

Monday, September 11 07.30 - 18.00 

Tuesday, September 12 07.30 - 18.00 

Wednesday, September 13 07.30 - 10.00 

Onsite Check-in Procedures 

Delegates must check in personally at their 

respective registration desk at the main 

entrance. There will be an express lane for preregistered 

delegates who are already in possession 

of their badges. Participants who have 

not received their badges when leaving their 

home country are requested to bring their letter 

of confirmation or a copy of the invoice. 

Badges 

After successful registration and payment, 

your personal congress badge and further 

information will be sent to the address indicated 

on your online registration form (registrations 

received and paid by August 10 th ). All 

participants registered after August 10 th will 

receive their badges at the registration desk. 

The personalised badge is your admission card 

to the congress. For organisational and security 

reasons, badges will have to be worn at the 

congress venue at all times. A lanyard will be 

given to you with the congress bag. Identity 

checks in the congress centre may occur at 

any time. 

In case of loss, a replacement badge will be 

provided for an administrative charge of € 50. 

Transportation in Rome 

Rome has an extensive integrated public 

transport system, which includes buses, an 

underground system, trams and a suburban 

train network. There are two underground 

lines; A and B. Line A runs east to west from 

Battistini to Anagnina and stops at many 

touristic sites such as the Vatican, Piazza di 

Spagna, Piazza Barberini and Piazza del 

Popolo. 

Palazzo dei Congressi 

Piazza John Kennedy, 1 

IT - 00144 Rome 

Italy 

Tel: +39 06 545 13701 

info@palazzocongressi.it 

www.palazzocongressi.it 

C RSE 


Line B runs northeast to southwest from 

Rebibbia to Laurentina. It stops at sites such as 

the Coliseum, Circus Maximus, St. Paul's 

Basilica and Eur Fermi (the stop closest to 

Palazzo dei Congressi). Line B connects Rome's 

three main railroad stations: Stazione 

Tiburtina, Stazione Termini and Stazione 

Ostiense. Both lines intersect at Stazione 

Termini. The underground runs from 5.30 am 

to 11.30 pm from Sunday to Friday and until 

00.30 am on Saturday. From midnight until 

6 am, there are special night line buses which 

cover different areas of the city and run 

approximately every 20 minutes. 

Please note the following changes due to construction 

work on underground Line A: the 

service ends at 9 pm. From 9 pm to 11:30 pm 

(on Saturdays from 9 pm to 00:30 am) a bus 

service operates between the following stops: 

- Bus MA1 Battistini to Arco di Travertino 

- Bus MA2 Washington to Anagnina 

The main radio-taxi network telephone numbers 

are: 063570, 0688177, 064994, 066645 

and 064157. The operators will provide you 

with an identification code that will allow you 

to recognise your taxi. 

CIRSE Shuttle Bus Service 

Most of the official CIRSE 2006 hotels are conveniently 

located in the heart of the city, most 

of them being approximately 20 minutes from 

the congress centre by taxi. In addition to the 

possibility of using the underground, shuttle 

bus lines will connect four pick up points near 

the hotels to the congress centre in the morning 

and evening hours. Furthermore, a shuttle 

bus will commute between the congress centre, 

the Sheraton and the nearby underground 

station throughout the day. 

Shuttle Bus Pick-up Points 

Via Veneto area: Via Boncompagni 

(corner Via V.Veneto) 

Exedra area: Piazza Esedra 

(in front of the Exedra hotel) 

Termini area: Via Cavour 15 

Prati area: Via Cicerone 55 

EUR area: Hotel Sheraton parking lot 

For further information on the shuttle bus service 

please refer to www.cirse.org or the CIRSE 2006 

pocket guide. 

Publication in CVIR 

15

Rome 2006 

Meeting abstracts as printed in this book will 

be published by Springer in an electronic supplementary 

issue of CVIR, the official CIRSE 

journal, and are therefore citable publications. 

We strongly encourage submission of the 

complete manuscript of any oral or poster 

presentation for publication in the journal, 

preferably in an electronic version through its 

website 

(http://mc.manuscriptcentral.com/cvr). Please 

note that submissions have to comply with 

the "Guidelines of Authors" specified in every 

issue of CVIR. 

Main Programme & Abstract Book 

A copy of the "Main Programme & Abstract 

Book" is provided in every congress bag. The 

bags are handed out at the congress check-in. 

Additional copies can be purchased at the registration 

desk at a rate of Euro 40.00 per book. 

EPOS TM 

EPOS TM is a pioneering system for an all-electronic 

scientific exhibition. The state-of-the-art 

database, which was developed by the 

European Congress of Radiology and generously 

made available to CIRSE, currently comprises 

more than 4,250 electronic presentations. 

EPOS TM offers much greater flexibility than traditional 

scientific exhibits and provides better 

options for scientific communication. The possibilities 

to use moving images, link to related 

websites, quickly search the entire scientific 

exhibition for specific topics in minute detail, 

e-mail entire exhibits and access EPOS TM from 

any computer connected to the internet are 

just some of its many advantages. 

The EPOS TM area is located on the first floor. 30 

computers will be available to view approximately 

260 electronic exhibits. 

EPOS TM Opening Hours 

Saturday, September 9, 07.30 - 18.00 

Sunday, September 10, 07.30 - 18.00 

Monday, September 11, 07.30 - 18.00 

Tuesday, September 12, 07.30 - 18.00 

Wednesday, September 13, 07.30 - 13.00 

Onsite EPOS TM staff will be glad to assist you 

during these hours. 

CME Credit Allowance 


CIRSE 2006 is accredited by the European 

Accreditation Council for Continuing Medical 

Education (EACCME) to provide the following 

CME activity for medical specialists. The EAC- 

CME is an institution of the European Union of 

Medical Specialists (UEMS), www.uems.net. 

CIRSE 2006 is designated for up to 27 hours of 

European external CME credits. Each medical 

specialist should claim only those hours of 

credit that he/she actually spent in the educational 

activity. 

EACCME credits are recognized by the 

American Medical Association towards the 

Physician's Recognition Award (PRA). To convert 

EACCME credit to AMA PRA category 1 

credit, contact the AMA. 

The CME-ICAP has granted 24 credit/hours to 

the congress. 

Certificate of Attendance 

To obtain your certificate of attendance, 

please choose one of the following options: 

Printing your certificate on site at the congress: 

You can print your certificate at the dedicated 

workstations in the Cyber Café. All you have to 

do is give your last name and the login details 

you were given after registering for the congress. 

Printing your certificate at home: 

After the congress you will have the possibility 

to print your certificate on our website 

(www.cirse.org). Again, all you will have to do 

is give your last name and login details in 

order to receive the certificate. 

Disclaimer 

CIRSE cannot accept any liability for the acts of 

the suppliers to this meeting or the attendees' 

safety while travelling to or from the congress. 

All participants are strongly advised to carry 

adequate travel- and health insurance, as 

CIRSE cannot accept liability for accidents or 

injuries that may occur. 

Financial disclosure and conflict of interest 

statements are available online at 

www.cirse.org 


17

society 


18 

�JOIN THE SOCIETY AND BECOME A CIRSE MEMBER 


Become a CIRSE Member 

… and enjoy our numerous membership benefits, 

including 

- reduced registration fees for the annual 

CIRSE Congress and the various scientific 

and educational events and workshops of 

the CIRSE Foundation 

- eligibility for the CIRSE Foundation's educational 

and research grants 

- a subscription to the CIRSE journal CVIR 

(Cardio Vascular and Interventional 

Radiology) 

- a subscription to IR News, the biannual 

CIRSE Newsletter 

- a 10% discount on books published by 

Springer 

- free access to the Members Lounge on the 

CIRSE website including CIRSE's Standards 

of Practice documents, EPOS, the online 

version of CVIR, the CIRSE Membership 

Directory and much more. 

Depending on your country of residence and 

professional status, you can apply for one of 

the following membership categories: 

C RSE 

C RSE 

Full Members 

Are physicians and scientists with an active 

interest and competence in Cardiovascular 

and Interventional Radiology, residing in 

Europe. They have the right to vote and hold 

office and are subject to the membership fees. 

Junior Members 

Are doctors in training residing in Europe. 

They have the right to vote and are subject to 

reduced membership fees. Junior Members 

automatically become Full Members after a 

maximum of 3 years of Junior Membership. 

Corresponding Members 

Are physicians and scientists residing outside 

of Europe. Corresponding Junior Members are 

doctors with an interest in Interventional 

Radiology residing outside of Europe. 

Corresponding Members and Junior Members 

do not have the right to vote or hold office, 

but are subject to the membership fees. 

Corporate Members 

Are corporations or other organisations, 

including commercial enterprises, irrespective 

of their place of incorporation or headquarters, 

interested in the activities and objectives 

of the Society. 

In order to become a member, please visit 

www.cirse.org and fill out the online application 

form.

IR News 

Learn the latest news on the Society, the 

CIRSE Foundation's activities and the annual 

CIRSE meeting with IR News, the official 

CIRSE Newsletter. Published biannually, IR 

News keeps you up to date with the latest 

developments in Cardiovascular and 

Interventional Radiology. The articles, written 

by some of the most prominent CIRSE 

members, cover a variety of subjects, 

including state of the art developments in 

IR technology and vital questions regarding 

the future of the field. As a member of 

CIRSE you will also have access to IR News 

online. 

19

20 

Rome, the Eternal City 

Almost since its beginnings Rome has fascinated mankind 

unlike any other city. For millennia, visitors to la città eterna 

have been captivated by its gorgeous monuments, cultural 

delights and timeless beauty. Here are some of 

Rome’s most beautiful sites which will make your days in 

Rome not only a professional, but also an incomparable 

cultural experience. 

The Colosseum 

Originally known as the Flavian Amphitheatre, the Colosseum 

was built by Vespasian in AD 72. With a capacity of approximately 

50.000 spectators it was the largest amphitheatre of 

antiquity. 

The Pantheon 

Originally built as a temple to the seven deities of the seven 

planets, the Pantheon became a Christian church in the 7 th century 

AD. It is one of the best preserved ancient monuments in 

Rome. 

The Roman Forum 

was the central area for commerce, administration, justice, cult 

and socializing around which ancient Rome developed. It comprises 

the remains of numerous temples, basilicas and arches. 

The Sistine Chapel 

The rectangular chapel designed by Baccio Pontelli and built in 

the late 1400s is most famous for Michelangelo’s frescoes. 

C RSE 

The Vatican 

Although not technically part of Italy, no trip to Rome would 

be complete without a visit to the Vatican. The tiny sovereign 

state headed by the Pope boasts some of the world’s most 

important architectural feats, including St. Peter’s Basilica and 

the Sistine Chapel. 

St. Peter’s Basilica 

Built on top of the burial site of St. Peter the apostle, it is considered 

one of the holiest sites in Christianity. Its 5.7 acres of 

floor space provide enough room for more than 60,000 people. 

The cathedral’s inside is decorated with innumerable masterpieces, 

such as Michelangelo’s Pietà. 

Trevi Fountain 

marks the end of the aqua virgo, one of Rome’s ancient aqueducts. 

Nicolò Salvi’s baroque masterpiece depicting Neptune 

and the taming of the waters and is an extremely popular 

meeting spot for tourists. Legend has it that those who throw a 

coin into the fountain will return to Rome one day. 

Castel Sant’Angelo 

The cylindrical building overlooking the Tiber River was originally 

built as a mausoleum. Later it served as a castle and 

fortress for more than 1,000 years. Today it houses a museum 

and is considered one of Rome’s most important medieval 

buildings.


Make www.cirse.org your startpage 

and keep up to date with the latest 

developments in Interventional 

Radiology. 

Make use of the many benefits you 

enjoy as a CIRSE Member by logging 

onto the Members Lounge. 

Within the Members Lounge you have 

access to all areas and services of the 

CIRSE website. 

1. "Edit Your Personal Data" gives you 

the possibility to carry out address 

changes, add to your list of interests and 

change your password. 

2. A click on the ESIR icons will enable 

you to register for the courses of the 

European School of Interventional 

Radiology. 

3. "My Confirmations" will let you view 

and print congress related documents 

4. Under "Membership Status and 

Payment" you can settle your membership 

dues or print out a payment confirmation. 

5. The "My Congress" button enables 

you to register for CIRSE 2006. 

6. Clicking on "My Hotel", you will have 

the possibility to make your reservation 

for one the official CIRSE hotels for this 

year’s congress. 

7. The CIRSE Membership Directory 

lets you browse and contact all CIRSE 

Members. 

Under "Publications" you can access 

E 3 IR; Electronic Education Excellence in 

Interventional Radiology, a tool that 

enables you to benefit once more from 

the educational material gathered at the 

CIRSE meetings. 

The Springer link provides access to 

the online version of CVIR and the possibility 

to search for articles published in 

previous issues. 

EPOS, The Electronic Presentation Online 

System, lets you browse and view more 

than 3.500 electronic presentations. 

Linking to the European Association of 

Radiology E-Learning Initiative, you 

will be able to view one of the biggest 

databases of radiology teaching files on 

the internet.

Rome 2006 

Session Types 

Foundation Courses 

Foundation courses will cover a specific area of Interventional 

Radiology, focusing on basic principles and illustrating the procedure 

in a step-by-step fashion. The foundation courses are 

designed for radiologists in training, new consultants and/or 

experienced consultants who require a refresher course on the 

subject. 

Biliary Intervention 

Saturday, September 09, 

12.00 - 13.00, Aula Magna 

SFA Angioplasty 

Monday, September 11, 

12.30 - 13.30, Aula Magna 

Special Session 

CIRSE meets India 

The "CIRSE meets" session is an excellent opportunity for 

European radiologists to experience Interventional Radiology 

in disease processes with which they may not be familiar. It is 

also a great opportunity to forge links with the Interventional 

Radiology community in countries outside of Europe. The invited 

country presents different topics introduced by experts in 

the relevant areas in a one hour session. 

Sunday, September 10, 

12.30 - 13.30, Aula Magna 

Film Interpretation Panel 

The film interpretation panel will consist of two teams, who will 

compete against each other. The teams will be given cases to 

diagnose and suggest treatment. One of the principle aims of 

the film panel is to demonstrate the approach an expert takes 

towards the solution of a diagnostic/therapeutic problem. This 

will be undertaken in an entertaining fashion and is not to be 

missed. The process will be a team effort. 

Tuesday, September 12, 

12.00 - 13.00, Aula Magna 

Morbidity and Mortality Conference 

The Morbidity and Mortality Conference will analyse 

Interventional Radiology cases that lead to complications 

and/or deaths that could have been avoided. This session provides 

a valuable learning experience for everyone involved in 

Interventional Radiology. 


14.00 - 15.15, Aula Magna 

Sessions 

Interactive Cases Discussion Forum 

The Interactive Cases Discussion Forums are divided into interactive 

case discussions on vascular cases, non-vascular cases 

and cases in which complications occurred. Two presenters will 

show individual cases and engage the audience's opinion on 

treatment. These case sessions are designed to be interactive 

and to impart a learning experience on how to work up difficult 

cases, approach difficult cases or deal with complications 

that may arise. 

Complications 


08.30 - 09.45, Room C 

Non-Vascular 


08.30 - 09.45, Room C 

Vascular 


08.30 - 09:45, Room C 

Interactive Case Session: Basic Vascular 

Diagnosis 

This session is designed to impart knowledge on vascular diagnosis 

at conventional angiography, MRA or CTA. It is designed 

for residents, fellows and/or junior consultants. The format 

consists of a presenter who will present cases to the audience 

and seek audience participation in diagnosis. 


10.15 - 11.30, Room B 


This programme consisting of several sessions throughout the 

congress is designed to teach the importance of proper 

research and documentation as well as the possibilities and 

consequences of FDA and EMEA inspections, among many 

other things. 

Saturday, September 9 - 

Wednesday, September 13, 

09:45-10:15 


11:30-12:00 

For further information on the Good Clinical Research Awareness 

Programme please refer to page 29. 


23

24 Workshops 

Workshops 

Virtual Reality Hands-on Workshops 

There will be two workshops on carotid stenting and one each 

on renal interventions and interventions in the lower limb. 

The aim of the workshops is to provide mentored experience 

of the sequencing of procedure steps and the use of interventional 

instruments. 

A total of six simulators supplied by various simulator manufacturers 

will be available. Participants will be able to perform the 

sequences of the target procedure in a virtual environment. 

The workshop will also provide an understanding of the current 

possibilities and limitations of simulator technology in the 

target procedures. 

During the two hours time slot, up to 18 participants will have 

the opportunity to experience computer-based simulation of a 

pre-selected topic/procedure. Further participants may attend 

as observers only. 

The session will start with a presentation by a CIRSE faculty 

member, followed by an introduction to the relevant simulator 

by a simulator technician. Each delegate will have 25 minutes 

of hands-on experience under the guidance of a CIRSE faculty 

member and technician. Faculty members will stay throughout 

the course to give feedback and discuss the procedures with 

the delegates. 

Carotid Stenting 


11:30 - 13:30, Ground Floor 



10:00 - 12:00, Ground Floor 

Renal Artery Intervention 


10:00 - 12:00, Ground Floor 

Intervention in the Lower Limb 

Wednesday, September 13, 

10:00 - 12:00, Ground Floor 

Instructors: D. Gould, A. Watkinson, J.-P. Beregi, P. Gaines, L. Lönn, 

S. McDonald, A. Patel, F. Perona, D. Vorwerk 

The workshop will take place on four different dates in the 

"Simulator Gallery" which will be located on the right hand side 

of the exhibition hall close to the meeting rooms. Workshop 

participation is limited (max. 24 participants per workshop). 

Pre-registration is required. 

Vertebroplasty Hands-on Workshops 

Due to the growing importance of Vetebroplasty within 

Interventional Radiology, CIRSE will once again offer a handson 

vertebroplasty workshop one day prior to the congress. 

The workshop will start with a 30 minute introduction to the 

principles and indications of the procedure, followed by a 

hands-on demonstration. Participants will then have the 

opportunity of practising needle placement, injection and the 

preparation of bone cement. All of the procedures will be carried 

out on plastic spine models under fluoroscopic guidance. 

The theoretical introduction and the hands-on demonstration 

will take place at the Policlinico Tor Vergata in Rome 

one day prior to CIRSE 2006. 

Policlinico Universitario Tor Vergata 

Viale Oxford 81 

00133 Rome 

SIV-HWS 1 

Friday, September 8, 

09:00 - 11:30 

SIV-HWS 2 


13:00 - 15:30 

SIV-HWS 3 


17:00 - 18:30 

Instructors: T. Sabharwal, A. Gangi, M. Bezzi, S. Masala, G. 

Anselmetti 

The CIRSE 2006 Vertebroplasty Workshop has been granted 

6 CME credits. 

Please note that the number of participants for each workshop 

is limited to 15. The registration fee is € 50. 

RFA Hands-on Workshops 

RF - Ablation 

Tips & Tricks in Radiofrequency Ablation 

This year's workshops will be made up of two basic and two 

advanced courses which will take about 90 minutes each. The 

workshop will start with a 45-minute theoretical introduction 

on how to improve the outcome of the procedure and 

decrease the chance of complications. 

Liver ablation and extrahepatic ablation will be discussed in 

both basic and advanced workshops. Extrahepatic ablation 

including kidney, bone and lung will be emphasized in the 

advanced workshop. The workshop will end with a 45-minute 

hands-on experience, which will deal with ultrasound-guided 

ablations in cow livers using different RF generators/electrodes. 

Each workshop can be attended by 25 participants. 

RFA-HWS Basic 1 


14:00 - 15:30, WS Room 1 

RFA-HWS Basic 2 


17:00 - 18:30, WS Room 1 

RFA-HWS Advanced 1 


15:30 - 17:00, WS Room 1 

RFA-HWS Advanced 2 


15:30 - 17:00, WS Room 1 


Instructors: M. Soulen, M. Bezzi, T. De Baere, T. K. Helmberger, R. 

Lencioni, L. Crocetti, L.Solbiati

Rome 2006 


The technical exhibition is located on the 

ground floor. 

Technical exhibition opening hours 

Saturday, September 9 11:00 - 17:00 

Sunday, September 10 09:00 - 17:00 

Monday, September 11 09:00 - 17:00 

Tuesday, September 12 09:00 - 17:00 

Wednesday, September 13 09:00 - 13:00 

CIRSE 2006 Exhibitors 

AB MedicaT 

Abbott Vascular Devices 

ALN Implants Chirurgiaux 

Angio Dynamics 

ArthroCare Europe AB 

Atrium Medical Corporation 

Barco 

Bard 

Baylis Medical 

BIBA Medical Limited 

Biosphere Medical 

BIOTRONIK 

Boston Scienfitic 

Bracco International 

Cardinal Health 

CeloNova BioSciences 

CIVCO Medical Solutions 

CORDIS 

Datascope 

Diomed 

Edizioni Minerva Medica 

Edwards Lifesciences 

EKOS Corporation 

Elastrat Sarl 

Endovascular Today 

Eucatech 

ev3 Europe 

GE Healthcare 

GUIDANT Europe NV/SA 

H.S. Hospital Service 

IDev Technologies Inc. 

INNOMEDIC 

InterV / Pbn Medicals 

Invatec Srl 

Kensey Nash Europe 

Lombard Medical Technologies 

C RSE 


MDS Nordion 

MDT Medical Development & Technology 

MEDAX S.r.l. 

Medcomp 

MEDRAD Europe 

Medtronic International 

Mentice AB 

Merit Medical Systems 

Olympus Winter & Ibe 

OptiMed 

pfm AG 

POSSIS Medical, Inc. 

Radius Medical Technologies, Inc. 

RITA Medical Systems, Inc. 

Schering AG 

Simbionix Ltd. 

SIRTeX Medical Europe 

SORIN Biomedica Cardio Srl 

Spectranetics International B.V. 

Springer the Language of Science 

St. Jude Medical Coordination Centre, 

Straub Medical AG 

Stryker S.A. 

Taewoong Medical Co. Ltd. 

Tecres Spa 

TeraRecon Inc. 

Terumo Europe 

Tyco Healthcare Holdings 

Vascular Solutions Inc. 

Vital Images 

W.L. GORE & Associates 

William Cook Europe 

Wisepress Ltd. 

Ziehm Imaging 

All information as per date of printing 

25

Rome 2006 


delivering what's next. 

Saturday, September 09 

13:15 - 13:45 

Room B 

Boston Scientific delivering what's next in radiofrequency ablation… 

How to select your patients for successful RFA in liver & lung 

T. de Baere; Villejuif/FR, A. Denys; Lausanne/CH 

Sunday, September 10 

11:45 - 12:15 

Room B 

Boston Scientific delivering what's next in lower limb therapies… 

Score and Chill: New technologies for diabetic foot 

T. McNamara; Los Angeles, CA/US 

Monday, September 11 

11:45 - 12:15 

Room B 

Boston Scientific delivering what's next in uterine fibroid embolisation… 

Predictors of clinical success in UFE: Why complete fibroid infarction is key and how to achieve it 

T.J. Kroencke; Berlin/DE 

Tuesday, September 12 

13:15 - 13:45 

Aula Magna 

Boston Scientific delivering what's next in carotid artery stenting… 


How do stent and embolic protection designs influence clinical outcomes in carotid artery stenting? 

M. Bosiers; Dendermonde/BE 


27

Rome 2006 


Good Clincial Research 

Good clinical trials are essential for the future of Interventional Radiology and although we see more and more good research, many 

of the current studies and publications are not performed according to internationally accepted standards for Good Clinical Practice. 

In order to get one's work published in high ranking journals, the implementation of good clinical practice is indispensable. It is 

essential to be aware of all the regulations and pitfalls in clinical research before starting a trial. European and a growing number of 

local healthcare authorities are introducing Good Clinical Practice in their regulations concerning clinical trials as well. 

Therefore it is essential to know about all of this before starting to research. 

CIRSE gives you the opportunity to learn more about this topic with a Good Clinical Practice Awareness Programme. Registration for 

the programme is free of charge for all CIRSE 2006 attendees. A certificate of attendance will be provided after the programme. 

I would urge all of those interested in clinical research in Interventional Radiology to attend this unique course. 

J. A. Reekers 

CIRSE Vice-President 

Saturday , September 9 

09:45 - 10:15 

Background of Good Clinical Practice 

At the end of this session the participant will 

- understand the impact of history on our current 

laws and guidelines 

- development and current status of the laws 

and guidelines 

- have a basic understanding of the applicable 

guidelines 

Saturday , September 9 

11:30 - 12:00 

EU guidelines and responsibilty 


- understand how compliance with GCP 

ensures that clinical trials are scientifically 

sound and allowing accurate reporting, 

interpretation and verification- 

- understand the importance of confidentiality 

- have a basic understanding of the possibility 

and consequences of FDA and EMEA inspections 

Sunday , September 10 

09:45 - 10:15 

Investigator & sponsor responsibilities 

according to Good Clinical Practice 


- have a basic understanding of the investigator 

& sponsor responsibilities in clinical 

research projects related to: 

- documentation 

- products / devices 

- protection of the safety and well being 

of the involved patients 

All sessions of the 

Good Clinical Research 

Awareness Programme 

will take place 

in Room I. 

C RSE 

Monday , September 11 

09:45 - 10:15 

Good Clinical Practice - Common findings 

Documentation and reporting 

Informed Consent Process 


- recognize the importance of obtaining 

informed consent 

- understand the importance of documentation 

and reporting responsibilities 

- have a basic understanding of how inspectors 

/ auditors will look and document possible 

findings 


09:45 - 10:15 

Common findings 2: Protocol 

deviations/Device accountability 


- understand the need for a protocol and what 

happens when deviations occur 

- understands the need for device accountability 

and the consequences if this is not performed 

correctly 

Wednesday, September 13 

09:45 - 10:15 

Common findings 3: Major adverse events 

vs. serious adverse events 


- understand the difference between Adverse 

Events, Serious Adverse Events and Major 

Adverse Events 

- understand the need for reporting this 

according to the laws, guidelines and protocol 

This programme has been made possible by 

an educational grant from CORDIS, J&J 

29

30 Social and Cultural Programme 

CIRSE Foundation Party 


CIRSE is proud to announce that this year's 

congress will feature another fund raising 

party in aid of the CIRSE Foundation. 

The backdrop for this year's event will be the 

stunning Villa Miani overlooking the city of 

Rome all the way to St. Peter's Cathedral. The 

exquisite dinner and outstanding entertainment 

programme will provide the perfect 

opportunity to celebrate the conclusion of our 

meeting. 

If you are interested in attending the 

Foundation Party, please visit our website 

(www.cirse.org) and go to CIRSE 2006 -> Social 

Events, where you will find a ticket order form. 

Accompanying Persons 

Programme 

Panoramic City Tour of Rome 


09.00 - 12.00 

Enjoy a panoramic tour of the Eternal City with 

its unique blend of cultural extravagance and 

luxury combined with its overindulgent 

nature. Together with our local guide you will 

have the opportunity to take a pleasant stroll 

through the historical centre, where you will 

be able to see the Spanish Steps, Trevi 

Fountain, Bernini's Palazzo di Montecitorio, 

Piazza Navona and the Panthoen, amongst 

many other things. 

Euro 33 per person 

Ancient Rome 


14.00 - 17.00 and 


09.00 - 12.00 

On this tour you will experience the splendour 

of the classic Roman Empire. 

The guided tour will take you to Capitol 

square, the result of Michelangelo's architectonic 

genius. From the Town Hall you will 

enjoy a unique view of the Forum and the 

Palatine Hill as well as of the Colosseum. You 

will then walk along the ancient pavement 

which crosses the evocative ruins of the 

Roman Forum, the Curia and the Reggia. You 

will then have the chance to visit the Temple 

of Vesta, the Arch of Titus and the Arch of 

Constantine. 


C RSE 


St. Peter and Vatican Museums 


07.30 - 11.30 

This tour will take you on a visit to the 

Vatican Museums, which are among the 

most important museums in the world. After 

taking the beautiful Spiral staircase we will 

continue through the Gallery of the 

Tapestries and the Gallery of the 

Geographical Maps before arriving in the 

famous Sistine Chapel where you will see 

Michelangelo's marvellous frescoes representing 

Creation and the Last Judgment. 

The tour will then continue with a visit to St. 

Peter Basilica, where four hundred statues 

await you, from Michelangelo's Pietà created 

in 1498 to more recent works representing 

the popes of the twentieth century. 


If you would like to know more about the CIRSE 

2006 Accompanying Persons Programme, 

please contact Kuoni Incoming at 

cirse 2006@kuoni.ch

Italian Orchestra Show 

CIRSE Opening Concert: Una grande Orchestra Italiana 

September 9, 16:30, Aula Magna 

CIRSE 2006 delegates are kindly invited to 

experience the all-time classics of Italian 

and international music performed by the 

BRAVO Orchestra. The concert is open to all 

congress attendees and accompanying persons 

and will be part of the opening ceremony 

which will take place on Saturday, 

September 9, 16.30-18.30 in the Aula 

Magna of the Palazzo dei Congressi. 

31

32 Scientific Programme Overview 

�Sep 09 

07:00 

Registration 


08:00 09:00 10:00 11:00 12:00 13:00 

15 30 45 15 30 45 15 30 45 15 30 45 15 30 45 

15 30 

Saturday 

Sunday 

Sep 10 

Monday 

Sep 11 

Tuesday 

Sep 12 

Wednesday 

Sep 13 

Special Sessions: p. 34 

Trauma 


Robotics for Interventional 

Procedures 


Clinical Practice 


Musculoskeletal Intervention 


Intermittent Claudication 1 


Stroke Therapy 

Interactive Case Discussion 

Forum 1: Complications p. 40 




IR in Liver Transplantation 




Forum 2: Non Vascular p. 48 


Renal Artery Intervention 


Thoracic Stent Grafts 




Forum 3: Vascular p. 51 


Vascular Imaging 1: 

Imaging of the Legs 


New IR Therapies 

for Cancer 


Uterine Fibroid 

Embolisation 

GCRAP 1 1 , p. 34 

GCRAP 3 1 , p. 40 

GCRAP 4 1 , p. 48 

GCRAP 5 1 , p. 52 

GCRAP 6 1 , p. 58 


Vascular Biology - Statins: 

Ubiquitous Therapy for all? 


UAE: where do we stand? 


IVC filters 


Lessons Learned 


Venous Insufficiency 


RF Ablation for 

Primary Liver Cancer 

Interactive Case Session 

Basic vascular diagnosis 

p. 48 


RF Ablation: 

Clinical Results 


IR/OR Suite of the Future 


AAA Stent Grafts 


Iliofemoral DVT 


Controversies in 

Non-Vascular IR 


Vascular Imaging 2: 

Plaque Imaging 


Controversies in Vascular IR 


Radiation Protection for 

Interventional Radiologists 

Satellite 

Symposia: 

Terumo 

Boston 

CTA: 

GE/ 

Siemens/ 

Toshiba 

p. 41 

Satellite 

Symposia: 

Boston 

Terumo & 

Biocompatibles 

Bayer 

p. 49 

Workshops 

15 30 45 15 30 45 15 30 45 15 30 45 15 30 45 

15 30 

08:00 09:00 10:00 11:00 12:00 13:00 

GCRAP 1 1 / Good Clinical Research Awareness Programme 1 

GCRAP 2 1 , p. 35 

Intermission - Exhibition 


Foundation Course: 

Biliary Intervention 

p. 36 

CIRSE Meets India 

p. 41 

Foundation Course: 

SFA Angioplasty 

p. 49 

Film 

Interpretation Panel 

p. 53 

p. 59 

Satellite 

Symposia: 

Abbott 

Boston 

Lombard 

p. 36 

Satellite 

Symposia: 

Boston 

Bracco/ 

Schering/ 

Guerbet 

Cordis 

p. 53

Rome 2006 

Scientific Programme Overview 

13:00 14:00 15:00 16:00 17:00 18:00 19:00 

15 30 45 15 30 45 15 30 45 15 30 45 15 30 45 15 30 45 

Satellite 

Symposia 

Satellite 

Symposia 

Satellite 

Symposia: 

Cook 

Cordis 

Biosphere 

p. 42 

Satellite 

Symposia: 

Gore 

Edwards 

GE 

p. 50 

Workshops 

p. 36 

Hands-on Workshop RFA 

Andreas 

Grüntzig 

Lecture 

Josef 

Roesch 

Lecture 

Intermission - 

Exhibition 

p. 42 

p. 50 

Morbidity & Mortality 

Conference/Vascular 

p. 53 

p. 36 


Exhibition 



Exhibition 

Free Papers 

p. 37ff 

Workshops 

General Assembly - 

for Members only 

Workshops 

CIRSE 

Opening Ceremony and Awards 

Concert 

Free Papers 

15 30 45 15 30 45 15 30 45 15 30 45 15 30 45 15 30 45 

13:00 14:00 15:00 16:00 17:00 18:00 19:00 

p. 43 


p. 54 


p. 42 

p. 50 

p. 53 

C RSE 

Workshops 

Free Papers 

p. 50 


p. 39 

p. 43ff 

p. 51 

p. 54ff 

Sat 

Sep 

09 

Sun 

Sep 

10 

Mon 

Sep 

11 

Tue 

Sep 

12 

Wed 

Sep 

13 

33

34 Scientific Programme 

Saturday, September 9, 2006 

08:30 - 09:45 

Session 1 Special Session Aula Magna 

Trauma 

Chairmen: V. Iaccarino (Naples/IT), A.A. Nicholson (Leeds/UK) 

1.1 Imaging strategies for the multiple trauma patient 

Y.K. Maratos; Paris/FR 

1.2 Can IR make a difference? 

F. Thony; Grenoble/FR 

1.3 Management of iatrogenic injury 

A.A. Nicholson; Leeds/UK 

08:30 - 09:45 

Session 2 Special Session Room F 

Robotics for Interventional Procedure 

Chairmen: A.A. Patel (Philadelphia, PA/US), D.A. Gould (Liverpool/UK) 

2.1 Value of robotics in patient care 

R. Bale; Innsbruck/AT 

2.2 MR guided robotic intervention 

A. Melzer; Gelsenkirchen/DE 

2.3 Robotic-assisted interventions for US and CT Guidance 

J. Kettenbach; Vienna/AT, G. Kronreif; Vienna/AT 

2.4 The future of robotics in medicine and health 

B. Siciliano; Napoli/IT 

08:30 - 09:45 

Session 3 Special Session Room B 

Clinical Practice 

Chairmen: C. Bartolozzi (Pisa/IT), R.I. White (Yale, CT/US) 

3.1 Setting up a clinical inpatient service 

G. Simonetti, S. Fabiano; Rome/IT 

3.2 How to setup an out patient department 

C.A. Binkert; Boston, MA/US 

3.3 The importance of daily rounds 

P.R. Mueller; Boston, MA/US 

3.4 Informed consent for IR 

M.J. Lee; Dublin/IE 

09:45 - 10:15 


09:45 - 10:15 

Good Clinical Research Awareness Programme 1 Room I 

Background of Good Clinical Research Awareness 

A. Talen; Antwerp/BE 

For details refer to page 29. 


Annual Meeting and Postgraduate Course

Rome 2006 


10:15 - 11:30 

Session 4 Special Session 

Vascular Biology Statins: Ubiquitous Therapy for All? Room F 

Chairmen: D.A. Allison (New Malden, Surrey/UK), E.-P. Strecker (Karlsruhe/DE) 

4.1 Atherosclerotic plaques: Pathophysiology 

D.P. Mikailides; London/UK 

4.2 Statins: Mechanisms of action 

J. Brittenden; Aberdeen/UK 

4.3 Who should take statins 

C.W. Kopp; Vienna/AT 

10:15 - 11:30 


UAE: Where do we stand? Aula Magna 

Chairmen: T.J. Kröncke (Berlin/DE), J. Reidy (London/UK) 

5.1 REST study results 

J.G. Moss; Glasgow/UK 

5.2 EMMY study results 

J.A. Reekers; Amsterdam/NL 

5.3 HOPEFUL study results 

K. McPherson; London/UK 

5.4 BSIR registry set-up and objectives 

A.A. Nicholson; Leeds/UK 

5.5 CIRSE registry set-up and objectives 

J.-P. Pelage; Boulogne/FR 

10:15 - 11:30 


IVC filters Room B 

Chairmen: G.R. Plant (Basingstoke, Hants/UK), M. Szczerbo-Trojanowska (Lublin/PL) 

6.1 Permanent filters -Do we still need them? 

J.A. Kaufman; Lake Oswego, OR/US 

6.2 Retrievable filters: The holy grail? 

F.G. Barral; Saint Etienne/FR 

6.3 Filter complications 

T.B. Kinney; San Diego, CA/US 

11:30 - 12:00 


11:30 - 12:00 


EU guidelines and responsibilities 



C RSE 

35


12:00 - 13:00 

Session 7 Foundation Course 

Biliary Intervention Aula Magna 

Chairman: M. Bezzi (Rome/IT) 

7.1 What information do I need before drainage? 

A. Hatzidakis; Heraklion/GR 

7.2 Biliary anatomy & Bismuth staging 

P.R. Mueller; Boston, MA/US 

7.3 Key points for success 

E. Brountzos; Athens/GR 

7.4 How to place a stent 

F. Fanelli, A. Conchiglia; Roma/IT 

7.5 When nothing works! 

H.-J. Wagner; Marburg/DE 

13:15 - 13:45 

Satellite Symposia 

14:00 - 15:00 

Session 9 Workshops 

Abbott 

Title: to be announced Aula Magna 

Boston Scientific delivering what's next in radiofrequency ablation… Room B 

How to select your patients for successful RFA in liver & lung 

T. de Baere; Villejuif/FR, A. Denys; Lausanne/CH 

Lombard 

Title: to be announced Room F 

9.1 Rescuing the failing A.V. fistula Aula Magna 

S. Trerotola (Philadelphia, PA/US), D. Vorwerk (Ingolstadt/DE) 

9.2 Venous access for beginners Room G 

F. Orsi (Milan/IT), F. McGrath (Dublin/IE) 

9.3 Biliary intervention Room F 

A. Adam (London/UK), K.A. Hausegger (Klagenfurt/AT) 

9.4 Embolisation for GI bleeding Room C 

M. Grosso (Cuneo/IT), J. Golzarian (Iowa City, IA/US) 

9.5 Building a clinical practice in IR Room E 

A.C. Roberts (La Jolla/US), A.D. Kelekis (Athens/GR) 

9.6 Arterial thrombolysis and limb salvage: How I do it Room B 

R. Gandini (Rome/IT), H.-J. Wagner (Marburg/DE) 

9.7 Conscious sedation for IR Room H 

P.R. Mueller (Boston, MA/US), H. Laasch (Manchester/UK) 

9.8 Renal artery intervention: Tips for success Room I 

M. Schoder (Vienna/AT), K.R. Thomson (Brighton/AU) 

9.9 Basic Paediatric intervention Room D 

E. Alexopoulou (Athens/GR), A.M. Cahill (Philadelphia, PA/US) 

14:00 - 15:30 

Hands-on Workshop 

Basic 1: Radiofrequency Ablation WS Room 1 

Organisers: T. De Baère (FR), R. Lencioni (IT) 

For details please refer to page 24. 



Rome 2006 


15:30 - 16:20 

Session 10.1 Free Papers 

Aortic stent graft (1) Room B 

Chairmen: M. D. Dake (Charlottesville, VA/US), H. Rousseau (Toulouse/FR) 

10.1.1 Complications of internal iliac artery embolisation prior to endovascular aneurysm repair 

R.D. Sayers, M. Glasby, K. Lambert, C. Karkos, M. McCarthy, G. Fishwick; Leicester/UK 

10.1.2 Retrograde aortic dissection: an underestimated complication after supracoronary aortic replacement 

in patients with Stanford type A aortic dissection 

A. Kovács, W. Schiller, T. Sommer, M. Hackenbroch, H.H. Schild, S. Flacke; Bonn/DE 

10.1.3 Internal iliac artery embolization during endovascular treatment of aortoiliac aneurysms: 

initial experiences with a nitinol vascular occlusion plug 

R. Kickuth, K. Ludwig, N. Diehm, D.-D. Do, I. Baumgartner, J. Triller; Berne/CH 

10.1.4 Endovascular graft infections: an update 

A. Calisti1, F. Speziale1, E. Ducasse2, V. Brizzi1, M. Ruggiero1, B. Ricci1; 1Rome/IT, 2Bordeaux/FR 

10.1.5 What proportion of thoraco-abdominal aortic aneurysms could be treated with branched/fenestrated stent grafts? 

A multidetector computed tomography-angiography study 

S. Desigan, C.D. Rodd, M.P. Jenkins, N.J. Cheshire, M. Hamady; London/UK 

15:30 - 16:20 


TIPS and portal vein intervention Room F 

Chairmen: J. I. Bilbao (Pamplona/ES), Z. Haskal (New York/US) 

10.2.1 Hemodynamic evaluation of the cirrhotic patient: does it matter where you measure the pressures? 

H. Ferral, G. Behrens, M.J. Alonzo, N.H. Patel; Chicago, IL/US 

10.2.2 Transjugular intrahepatic portosystemic shunt creation in Budd-Chiari syndrome: 

utility of percutaneous ultrasound-guided simultaneous puncture of the portal vein and the inferior vena cava 

F. Boyvat1, C. Aytekin1, U. Ozyer1, L. Oguzkurt2, E. Yildirim3, M. Haberal1; 1Ankara/TR, 2Adana/TR, 3Konya/TR 

10.2.3 Short- and long-term effects of transjugular intrahepatic shunt on cardiac function 

A. Kovács, T. Sommer, M. Hackenbroch, M. Schepke, H.H. Schild, S. Flacke; Bonn/DE 

10.2.4 Results of a multicenter randomized trial of distal spleno-renal shunt versus transjugular intrahepatic 

portosystemic shunt to control refractory variceal bleeding in Child's A or B cirrhosis 

L.G. Martin1, M. Geisinger2, J. Guerra, Jr. 3, M. Wojtowycz4, F.L. Thaete5, A. Zajko5, J.M. Henderson2; 1Atlanta, GA/US, 

2Cleveland, OH/US, 3Miami, FL/US, 4Madison, WI/US, 5Pittsburg, PA/US 

10.2.5 Pre-extended hepatectomy portal vein embolization for future liver remnant hypertrophy 

using n-butyl cyanoacrylate 

J.G. Caridi, S. Meader, S. Wiley, A. Hemming, D. Vermess; Gainesville, FL/US 

15:30 - 16:20 


Aortic stent graft (2) Room C 

Chairmen: D. A. Kelekis (Athens/GR), S. Müller-Hülsbeck (Kiel/DE) 

10.3.1 Endovascular treatment of acute and chronic thoracic aortic injury 

J. Raupach, M. Lojik, A. Ferko, A. Krajina, J. Harrer, V. Chovanec; Hradec Kralove/CZ 

10.3.2 Endovascular treatment of descending thoracic aorta. A new-concept prosthesis for a complex pathology 

I.P. Vulev, M. Holoman, J. Madaric, M. Vozar, J. Luptak, P. Lesny, Z. Ravingerova; Bratislava/SK 

10.3.3 Incidental pathology detected on routine computed tomography in relation to 

endovascular aneurysm repair is a significant problem 

H. Ballal, J. West, J.A. Brennan, G.L. Gilling-Smith, D.A. Gould, P.L. Harris, R.G. McWilliams, 

M. Murphy, S.R. Vallabhaneni; Liverpool/UK 

10.3.4 Endovascular repair of abdominal aortic aneurysms: virtual planning 

F. Perona, A. Annoni, L. Andreoni, M. Midulla, C. Missiroli, G. Cornalba; Milan/IT 

10.3.5 Endoleak classification after abdominal aortic aneurysm stent-grafting: 

computed tomography-angiography versus contrast-enhanced ultrasonography 

G. Carrafiello, D. Laganà, M. Mangini, C. Recaldini, P. Martinoli, M. Dizonno, C. Fugazzola; Varese/IT 

C RSE 

37


15:30 - 16:20 


Venous intervention Room G 

Chairmen: P. Goffette (Brussels/BE), K. Kandarpa (Worcester/US) 


10.4.1 Transcather embolization of male varicocele with Fibro-Vein mousse infusion: experience with 340 patients 

M. Chiocchi, C. Reale, A. Spinelli, L. Maresca, R. Gandini, G. Simonetti; Rome/IT 

10.4.2 Incidence of large perforating collaterals between the incompetent great saphenous vein and the femoral vein 

R.L. Worthington-Kirsch; Philadelphia, PA/US 

10.4.3 Transjugular pelvic vein embolisation in the pre-operative management of patients 

with pelvic vein reflux undergoing leg vein surgery 

A.J. Lopez, F.F. Hussain, J.M. Holdstock, C. Harrison, B.A. Price, M.S. Whiteley; Guildford/UK 

10.4.4 Percutaneous bioprosthetic valve placement for treatment of deep vein insufficiency: a safety clinical study 

D. Pavcnik 1, J. Kaufman 1, L. Machan 2, E. Uruchurtu 3, E.N. Brountzos 4, K. Thomson 5, B. Case 6, C.L. McIntosh 6, F.S. Keller 1; 

1Portland, OR/US, 2Vancouver, BC/CA, 3Mexico City/MX, 4Athens/GR, 5Melbourne/AU, 6Bloomington, IN/US 

10.4.5 Primary bilateral varicocele sclero-embolization: preliminary report on the effect on birth rate 

M. Morucci, P. Agresti, G. La Pera, F. Romanelli, L. De' Medici; Rome/IT 

15:30 - 16:20 


Clinical practice, Simulation and Risk Management Room D 

Chairmen: G. Bartal (Kfar-Saba/IL), K. L. Krol (Indianapolis, IN/US) 

10.5.1 Does Interventional Radiology have a future as a clinical speciality? - A survey of General Practitioner perceptives 

S. Desigan, M. Al-Qaisi, S. de Cesare, M. Hamady; London/UK 

10.5.2 Porcine transfer study: does virtual reality simulator training compare to porcine training in endovascular novices? 

M. Berry1, T. Lystig1, J. Beard2, R. Reznick3, L. Lonn1; 1Gothenburg/SE, 2Sheffield/UK, 3Toronto, ON/CA 

10.5.3 How do Patients Perceive the Benefits and Risks of Peripheral Angioplasty? 

S.B. Habib1, T.C. See2, L. Sonoda2, P.J. Ell3, A. Groves3; 1Nottingham/UK, 2Cambridge/UK, 3London/UK 

10.5.4 Deriving metrics for objective assessment in interventional radiology using cognitive task analysis 

D.A. Gould, A.E. Healey, S.J. Johnson; Liverpool/UK 

10.5.5 Radiation exposure of the interventional radiologist during different procedures 

J. Schneider, S. Herber, C. Düber, M.B. Pitton; Mainz/DE 

15:30 - 16:20 


Renal artery and dialysis fistula intervention Room E 

Chairmen: A. M. Al-Kutoubi (Beirut/LB), L. Turmel-Rodrigues (Tours/FR) 

10.6.1 Treatment of plicature-induced transplant renal artery stenosis by primary stenting: 

technical results and clinical outcome 

P.P. Goffette, M. Mourad, J.-P. Squifflet, E. Danse; Brussels/BE 

10.6.2 Renaissance trial: a prospective, multicenter trial to confirm the safety and efficacy 

of the Express® SD stent for treating renal artery stenosis 

K. Rocha-Singh; Springfield, IL/US 

10.6.3 The role of interventional radiology in the management of kidney transplant complications 

F. Fontana, G. Carrafiello, D. Laganà, M. Mangini, C. Recaldini, G. Dionigi, A. Bacuzzi, C. Fugazzola; Varese/IT 

10.6.4 The benefit of stent placement and blood pressure and lipid-lowering for the prevention of progression of 

renal dysfunction caused by atherosclerotic ostial stenosis of the renal artery. 

The STAR-study: baseline data and early technical results 

L. Bax, W.P. Mali, E. Buskens, H.A. Koomans, J.J. Beutler; Utrecht/NL 

10.6.5 Incidence and percutaneous management of arterial emboli occurring during hemodialysis graft recanalization 

D.E. Goo, Y.J. Kim, C. Moon, D. Song; Seoul/KR 

Cardiovascular and Interventional Radiological Society of Europe

Rome 2006 


15:30 - 16:20 


Angioplasty (Experimental) Room H 

Chairmen: R. W. Günther (Aachen/DE), K. Valji (San Diego/US) 

10.7.1 Inflammation slows endothelialization in restenosis 

M.A. Cura, E.A. Sprague; San Antonio, TX/US 

10.7.2 Structural characteristics of a composite material stent knitted with a metallic wire 

and a non-metallic fiber: comparison with a metallic stent 

Y. Shomura1, N. Tanigawa1, T. Tokuda1, S. Kariya1, A. Komemushi1, H. Kojima1, S. Sawada1, R. Marui2, A. Nakai2, H. Hamada2; 1Hirakata/JP, 2Kyoto/JP 

10.7.3 Magnetic resonance-labeled mesenchymal stem cells for therapeutic angiogenesis 

L.V. Hofmann1, W.D. Gilson2, D. Kedziorek2, T. Patel2, M. Stuber2, J.W. Bulte2, D.L. Kraitchman2; 1Stanford, CA/US, 

2Baltimore, MD/US 

10.7.4 Comparison between the Sirolimus-eluting, biodegradable, poly-L-lactic acid, vascular stent 

and a stainless steel stent in a porcine model 

C. Kröger, K. Sternberg, N. Grabow, L. Ketner, M. Goosmann, C.M. Bünger, J.C. Kröger; Rostock/DE 

16:30 - 18:30 

Opening Ceremony and Concert Aula Magna 

Gold Medalist: B.T. Katzen; Miami, FL/US 

Laudation: J. Lammer; Vienna/AT 

Distinguished Fellow: A. Rosenberger; Haifa/IL 

Laudation: G. Bartal; Kfar-Saba/IL 

Distinguished Fellow: G. Simonetti; Rome/IT 

Laudation: R. Passariello; Rome/IT 

EPOS Awards 

CVIR Editor's Medal: I. Bargellini; Pisa/IT 

The concert is open to all congress attendees and accompanying persons 

Sunday, September 10, 2006 

08:30 - 09:45 


Musculoskeletal Intervention Room F 

Chairmen: H. Deramond (Fort de France - Martinique/FR), T. Sabharwal (Bromley, Kent/UK) 

12.1 RF ablation of bone lesions 

A. Gangi; Strasbourg/FR 

12.2 Vertebroplasty: What is the evidence 

J.-B. Martin; Chêne-Bougerie/CH 

12.3 Bone biopsy techniques 

A.D. Kelekis; Athens/GR 

12.4 Disc and facet joint IR treatments 

R.M. Seibel; Mülheim an der Ruhr/DE 

08:30 - 09:45 


Intermittent Claudication 1 Aula Magna 

Chairmen: F. Keller (Portland, OR/US), C. Zollikofer (Wintherthur/CH) 

13.1 Prevalence, risk factors & epidemiology 

F. Moll; Utrecht/NL 

13.2 History and Clinical Examinations: What can be learned 

C. Kelly; Dublin/IE 

13.3 Interpretation of non-invasive imaging tests 

T. Rand; Vienna/AT 

13.4 MRA vs CTA 

C. Catalano; Rome/IT 

39


08:30 - 09:45 


Stroke Therapy Room B 

Chairmen: P. Brennan (Dublin/IE), K. Mathias (Dortmund/DE) 

14.1 Current strategies for imaging stroke patient 

N. Anzalone; Milan/IT 

14.2 Stroke lysis & when to do it? 

P. Lylyk; Buenos Aires/AR 

14.3 Outcomes of Lysis 

A. Besim; Ankara/TR 

14.4 Post procedure care 

J. Moroney; Dublin/IE 

08:30 - 09:45 

Session 15 Interactive Case Discussion Forum 1 

Complications and how to deal with them Room C 

R.A. Morgan (London/UK), G.J. O'Sullivan (Galway/IE) 

09:45 - 10:15 


09:45 - 10:15 


Investigator & sponsor responsibilities 



10:15 - 11:30 


Lessons Learned Room F 

Chairmen: J. Namyslowski (Peoria, IL/US), D. Vorwerk (Ingolstadt/DE) 

16.1 Carotid stenting 

C. Rabbia; Turin/IT 

16.2 EVAR 

R.A. Morgan; London/UK 

16.3 UFE 


10:15 - 11:30 


Venous Insufficiency Aula Magna 

Chairmen: J.A. Brookes (London/UK), S. Kundu (Richmond Hill/CA) 

17.1 Anatomy, patient selection and work up 

A. Mavor; Leeds/UK 

17.2 Tools for ablation & sclerotherapy 

D.J. West; Stoke on Trent/UK 

17.3 How I do it 

L. Machan; Vancouver/CA 

17.4 Outcome and follow up 

R.L. Worthington-Kirsch; Philadelphia/US 



Rome 2006 


10:15 - 11:30 


RF Ablation for Primary Liver Cancer Room B 

Chairmen: R. Lencioni (Pisa/IT), M.C. Soulen (Lafayette Hill, PA/US) 

18.1 Principles and device selection 

T.K. Helmberger; Lübeck/DE 

18.2 Tips for a successful ablation 

L. Solbiati; Busto Arsizio/IT 

18.3 Management of the Post-Ablation Patient 

G.D. Dodd; San Antonio/US 

18.4 Therapeutic management of patients with liver cancer 

J.M. Llovet; New York/US 

11:45 - 12:15 


Terumo 

Challenges in renal stenting Aula Magna 

Chairman: M. Sapoval; Paris/FR 

How to recruit patients 

M. Downes; Canterbury/UK 

ODORI Registry preliminary results 

H.T. Abada; Cergy-Pontoise/FR 

Boston Scientific delivering what's next in lower limb therapies… Room B 

Score and Chill: New technologies for diabetic foot 

T. McNamara; Los Angeles, CA/US 

GE, Siemens, Toshiba 

Latest trends for peripheral CTA Room F 

Pre and post endovascular intervention: early experience on new post-processing tools 

A. Azarine; Paris/FR; A. Redheuil; Paris/FR 

New insights in cardiac CT - DSCT 

C. Becker; Munich/DE 

Advanced volumetric CT - Today and tomorrow 

L. Bouwman; Zoetermeer/NL 

12.30 - 13:30 


CIRSE meets India Aula Magna 

Chairmen: J. Lammer (Vienna/AT), S. Sharma (New Delhi/IN) 

20.1 ISVIR - Objectives, activities and current status 

A.K. Gupta; Trivandrum/IN 

20.2 Current concepts in the management of IVC and hepatic vein occlusion 

S. Punamiya; Mumbai/IN 

20.3 Interventional radiology in the management of tubercle induced hemoptysis 

M. Charian; Coimbatore/IN 

20.4 Endovascular management of symptomatic lesions in nonspecific aortitis 

S. Sharma; New Delhi/IN 

20.5 Current status of IR research in India 

J. Venkateshwarulu; Hyderabad/IN 

C RSE 

41


13:45 - 14:15 


Cook 

Peripheral destinations: The future of drug eluting stents 

in the legs and renals Aula Magna 

The use of drug eluting stents in the SFA in general 

to be announced 

Renal stenting and potential for drug eluting stents in the renal artery 


Different drugs to stents, behaviour and the uses of polymer and why not. 


Stents on drugs in different places 


Cordis 

New developments in carotid stenting Room B 

Growing evidence for carotid stenting 


The CASES carotid training program 


Biosphère Medical 

Drug Delivery HepaSphere: clinical experience 

in the treatment of liver tumors Room F 

Chairman: M. Ryan; Dublin/IE 

Technical Aspects 

M. Grosso; Cuneo/IT 

Clinical Aspects 

C. Massasaluzzo; Pavia/IT 

14:30 - 15:15 

Session 22 Andreas Grüntzig Lecture 

Interventional oncology: image-guidance 

propelling the future of cancer therapy Aula Magna 

L. Solbiati; Busto Arsizio/IT 

Laudation: R. Lencioni; Pisa/IT 

15:15 - 15:45 


15:30 - 17:00 


Advanced 1: Radiofrequency Ablation WS Room 1 





Rome 2006 

15:45 - 16:45 



23.1 Enternal nutrition and the interventional radiologist Room I 

H. van Overhagen (The Hague/NL), P.J. Haslam (Newcastle upon Tyne/UK) 

23.2 Aortoiliac angioplasty and stenting: how I do it Room B 

E.-P.K. Strecker (Karlsruhe/DE), H. Vernhet-Kovacsik (Montpellier/FR) 

23.3 EVAR: lessons for beginners Room C 

F. Fanelli (Rome/IT), P. Kennedy (Belfast/UK) 

23.4 UAE: What you need to know Aula Magna 

J.A. Reekers (Amsterdam/NL), N. McEniff (Dublin/IE) 

23.5 Embolisation materials: What should I use and where? Room F 

G.M. Richter (Heidelberg/DE), M. Szczerbo-Trojanowska (Lublin/PL) 

23.6 Venous insufficiency: Clinical appraisal and Doppler examination Room E 

M. Weston (Leeds/UK), S. Kundu (Scarborough/CA), 

L. Machan (Vancouver/CA), A. Mavor (Leeds/UK) 

23.7 Endovenous ablation: Sclerotherapy, laser and RF Room H 

R.L. Worthington-Kirsch (Philadelphia/US), 

D.J. West (Stroke on Trent, Staffs/UK) 

23.8 TIPS: How I do it Room G 

A. Krajina (Hradec Kralove/CZ), J. Bilbao(Pamplona/ES) 

23.9 Evidence based practice in interventional radiology Room D 

L. Crocetti (Pisa/IT), D. Malone (Dublin/IE) 

17:00 - 18:30 


Uterine Artery Embolization Aula Magna 

Chairmen: J.-P. Pelage (Paris/FR), I. Pinto Pabón (Madrid/ES) 

24.1.1 Effectiveness of uterine artery embolization in patients desiring future pregnancy 

B.Y. Bobrov, S.A. Kapranov; Moscow/RU 

24.1.2 Safety of uterine artery embolization in large-sized fibroids 

J.M. Pisco, M. Duarte, M.M. Monteiro, D.D. Santos, A. Guerra, J. Castaño, F.M. Pires; Lisbon/PT 

24.1.3 Fluoroscopically-guided placement of Essure fallopian tube microinserts 

for permanent birth control in women status-post uterine artery embolization for fibroid disease 

R.L. Worthington-Kirsch; Philadelphia/US 

24.1.4 Outpatient uterine artery embolization for fibroids 

J.M. Pisco, M. Duarte, M.M. Monteiro, D.D. Santos, A. Guerra, J. Castaño, F.M. Pires; Lisbon/PT 

24.1.5 Flouroscopic times and radiation doses during uterine fibroid embolisation: 

lessons learned from the UK fibroid registry 

A.R. Owen, J.G. Moss; Glasgow/UK 

24.1.6 Endocrine and reproductive aspects of uterine fibroid embolization 

M. Mara, J. Maskova, Z. Fucikova, O. Sosna, D. Kuzel; Prague/CZ 

24.1.7 Early efficacy of uterine fibroid embolization in fibroids with bulk-related symptoms 

P. Bermudez, J. Falco, J. Branera, J. Costa, L. Costa, L. Tortajada, J. Perendreu, J.R. Fortuño; Sabadell/ES 

24.1.8 Randomised comparison of uterine artery embolisation with surgical treatment 

in patients with fibroids (REST trial): one-year results 

J.G. Moss; Glasgow/UK 

24.1.9 Location of trisacryl-gelatin microspheres in fibroids according to size 

J.P. Pelage 1, M. Wassef 2, J. Isaac 2, D. Jacob 2, T. Meatchi 2, A. Laurent 2; 1Boulogne sur Seine/FR, 2Paris/FR 

C RSE 

43


17:00 - 18:30 


Peripheral Angioplasty (1) Room B 

Chairmen: P. Haage (Wuppertal/DE), M. Maynar (S/C Tenerife/ES) 

24.2.1 Cryoplasty in arterial restenosis 

S. Karthik, D.J. Tuite, A.A. Nicholson, J.V. Patel, D.R. Shaw, S. McPherson, D.O. Kessel; Leeds/UK 

24.2.2 Absorbable metal stents in patients with critical limb ischemia. One-month interim results 

of AMS-INSIGHT 1 study: a randomized trial with absorbable metal stents 

M. Bosiers1, K. Deloose1, J. Verbist2, P. Peeters2; 1Dendermonde/BE, 2Bonheiden/BE 

24.2.3 Evaluation of stent fractures after lower limb artery stenting with special regard 

to the stent types and the clinical impact 

G. Wittenberg, A. Halla, C. Ritter, M. Hoehmann, D. Hahn; Würzburg/DE 

24.2.4 Interim results of the below-the-knee CHILL study 

T.O. McNamara1, T. Das2, B. Gray3; 1Los Angeles/US, 2Dallas/US, 3Greenville/US 

24.2.5 Intravascular ultrasound-guided fenestration of vascular dissections 

by using the Pioneer catheter: a novel therapeutic catheter technique 

R. Kickuth, K. Ludwig, D.-D. Do, I. Baumgartner, J. Triller; Berne/CH 

24.2.6 Percutaneous treatment in iliac artery occlusions: long-term results 

M. Chiocchi, S. Fabiano, M. Messina, L. Maresca, R. Gandini, G. Simonetti; Rome/IT 

24.2.7 Twelve-month results of FAST: femoral artery stenting trial 

H. Krankenberg1, T. Tübler1, H.J. Steinkamp2; 1Hamburg/DE, 2Berlin/DE 

24.2.8 Long-term results after infrapopliteal angioplasty 

H. Alfke1, A. Vannucchi2, K.J. Klose2, H.-J. Wagner2; 1Luedenscheid/DE, 2Marburg/DE 

24.2.9 Flanders experience with endovascular treatments for below-the-knee-lesions 

in critical limb ischemia-patients: the FEET-BTK study 

M. Bosiers1, J.P. Hart1, K. Deloose1, J. Verbist2, P. Peeters2; 1Dendermonde/BE, 2Bonheiden/BE 

17:00 - 18:30 


Bone and soft Tissue Intervention Room F 

Chairmen: A. Gangi (Strasbourg/FR), A. Kelekis (Athens/GR) 


24.3.1 Percutaneous discectomy under computed tomography and fluoroscopic guidance: 

six to 24 months of follow up. Report on 50 cases 

N. Amoretti, P. David, I. Hovorka, A. Grimaud, C. Grisot, P. Boileau, J.-N. Bruneton; Nice/FR 

24.3.2 Percutaneous nucleoplasty in the treatment of disc lumbar pain 

S. Masala, A. Ursone, F. Massari, R. Fiori, G. Simonetti; Rome/IT 

24.3.3 Radiofrequency ablation in the treatment of osteoid osteoma 

R.-T. Hoffmann1, T.F. Jakobs1, C.G. Trumm1, T.K. Helmberger2, M.F. Reiser1; 1Munich/DE, 2Luebeck/DE 

24.3.4 Polymethyl methacrylate cement compared with Calcibon® in kyphoplasty of painful osteoporotic 

vertrebral fractures. Three-year outcomes of a prospective cohort study 

G. Noeldge, I. Grafe, K. DaFonseca, M. Libicher, P. Meeder, C. Kasperk, G.W. Kauffmann; Heidelberg/DE 

24.3.5 Percutaneous vertebroplasty in patients with osteoporotic fractures of the spine: medium-term clinical outcome 

C.G. Trumm, T.F. Jakobs, M.F. Reiser, R.-T. Hoffmann; Munich/DE 

24.3.6 Plasma radiofrequency-based discectomy (Coblation) for treatment of cervical herniated 

nucleus pulposus: feasibility, safety and preliminary clinical results 

G. Bonaldi1, F. Baruzzi2, A. Facchinetti2, P. Fachinetti2, S. Lunghi2; 1Bergamo/IT, 2Varese/IT 

24.3.7 Post-vertebroplasty posture, standing, and walking habits measurements in relation to pain scores 

A.D. Kelekis1, C. Vergadis1, J.-B. Martin2, N. Tasiopoulos1, K. Mystakidou1, E. Katsouda1, F. Stripeli1, K. Malagari1, N. Nassis1, A. Gouliamos1; 1Athens/GR, 2Geneva/CH 

24.3.8 "Vertos-II" trial: vertebroplasty versus conservative therapy in patients with osteoporotic 

vertebral compression fractures 

C.A. Klazen1, P.N. Lohle1, H. Fransen2, L.E. Lampmann1, T.H. Lo3, M.H. Voormolen1, K.J. van Everdingen3, G.A. de Kort3, M.C. Schoemaker1, W.P. Mali3; 1Tilburg/NL, 2Gent/BE, 3Utrecht/NL 

24.3.9 Incidence of adjacent and distant fractures during follow-up after computed tomography-guided vertebroplasty 

M.B. Pitton, S. Herber, J. Schneider, N. Morgen, P. Drees, B. Böhm, C. Düber; Mainz/DE 


Rome 2006 


17:00 - 18:30 


Carotid artery stenting Room C 

Chairmen: H. Manninen (Kuopio, FI), K. Mathias (Dortmund/DE) 

24.4.1 Do device characteristics impact outcome in carotid artery stenting? 

M. Bosiers1, J.P. Hart1, K. Deloose1, J. Verbist2, P. Peeters2; 1Dendermonde/BE, 2Bonheiden/BE 

24.4.2 Does the embolized debris collected in protection filters during carotid artery stenting 

correlate with angiographic findings? 

A. Razuk, G. Novaes, G. Pozzan, W. Karakhanian, A. Fioranelli, V. Castelli Jr., R. Caffaro, J. Park, P. Saad; Sao Paulo/BR 

24.4.3 The relationship between post-carotid artery stenting hypotension and stent type 

B.T. Katzen, M.E. Kovacs, G. Zemel, J.F. Benenati, A. Powell, S. Samuels, C. Pena; Miami/US 

24.4.4 Cerebral ischemia after filter-protected carotid artery stenting is common and 

cannot be predicted by the presence of substantial amount of debris captured by the filter device 

G.A. Maleux, P. Demaerel, E. Verbeken, K. Daenens, S. Heye, F. Van Sonhoven, A. Nevelsteen, G. Wilms; Leuven/BE 

24.4.5 Strategies for the management of carotid stenting using cerebral protection: 

our experience in the first 100 patients 

M. Natrella, L. Mistretta, E. Muraro, M. Cristoferi, D. Machado, T. Meloni; Aosta/IT 

24.4.6 Sirolimus-eluting stents in the carotid artery. Increased inflammation but persistent prevention 

of restenosis in follow-up 

G. Tepe1, F. Reddig1, C.D. Claussen1, S.H. Duda2; 1Tübingen/DE, 2Berlin/DE 

24.4.7 Endovascular treatment of internal carotid artery stenosis: immediate and five-year follow-up 

M. Stefanini, R. Gandini, S. Fabiano, A. Spinelli, C. Reale, E. Pampana, G. Simonetti; Rome/IT 

24.4.8 Carotid RX ACCULINK/ACCUNET post-approval trial to uncover unanticipated or rare events 

(CAPTURE): status update on 2500 patients 

M.H. Wholey1, M.H. Wholey2; 1Pittsburgh/US, 2San Antonio/US 

24.4.9 Does residual stenosis influence a long-term in-stent patency after carotid artery stenting? 

T. Jargiello, W. Krzyzanowski, A. Drelich-Zbroja, J. Wojczal, M. Szczerbo-Trojanowska; Lublin/PL 

24.4.10 "Best of SIR" - Carotid stenting without cerebral protection: results in 400 patients 

F. Perona, A. Curti, G. Dalla Pietà, L. Valvassori, E. Boccardi, G.P. Cornalba; Milan/IT 

17:00 - 18:30 


IVC filters Room G 

Chairmen: F.-G. Barral (St. Etienne/FR), F. Keller (Portland, OR/US) 

24.5.1 The Option vena cava filter: conical, retrievable, self- centering, true 6F 

J.F. McGuckin; Radnor/US 

24.5.2 The Recovery inferior vena cava filter. Placement and retrieval experience 

E. Hayeems; Toronto/CA 

24.5.3 Günther Tulip retrievable inferior vena cava filters: indications, complications, efficacy and retrieval 

S. Looby, M.F. Given, A. Geoghegan, A. McErlean, M.J. Lee; Dublin/IE 

24.5.4 New optional inferior vena cava filter: in-vivo comparative study in an ovine model. Günther Tulip versus Celect 

D.L. Bonilla1, A. Mølgaard-Nielsen2, M. Sanchez1, T. Higuera1, A. Laborada1, F. Lostale1, M.A. De Gregorio1; 1Zaragoza/ES, 2Denmark/DK 

24.5.5 Günther Tulip inferior vena cava filter in an ovine model: retrievable force study 

T. Higuera1, A. Mølgaard-Nielsen2, D.L. Bonilla1, A. Viloria1, M. Sanchez1, F. Lostale1, M.A. De Gregorio1; 1Zaragoza/ES, 2Denmark/DK 

24.5.6 Additional clinical experience with a long-term retrieval optional vena cava filter 

F.G. Barral1, J.-P. Beregi2; 1Saint-Etienne/FR, 2Lille/FR 

24.5.7 A clinical comparison between two optional caval filters 

T. Pfammatter, I.S. Keller, R. Pfiffner, C. Meier, E. Keller, B. Marincek; Zürich/CH 

24.5.8 Günther Tulip optional vena cava filter: retrieval after four-week implantation. 

A preliminary prospective clinical study 

T. Higuera, M. Sanchez, D.L. Bonilla, J. Medrano, A. Mainar, M.A. De Gregorio; Zaragoza/ES 

24.5.9 The Guenther-Tulip retrievable filter: A method of assessing tilting of the filter 

A. Semiz-Oysu, K.J. Cho; Ann Arbor/US 

C RSE 

45


17:00 - 18:30 


Imaging challenges for IR Room I 

Chairmen: C.A. Lewis (Atlanta, GA/US), C. Rabbia (Turin/IT) 


24.6.1 Blunt Splenic Injuries: CT-Angiographic Correlates and Efficacy of CO2 DSA 

A. Semiz-Oysu, E. D'Souza, K.J. Cho; Ann Arbor/US 

24.6.2 Contrast-induced nephropathy: practical guidance for clinicians 

C.R. Becker 1, F. Stacul 2, J. Tumlin 3, A. Adam 4, C. Davidson 5, N. Lameire 6, P.A. McCullough 7; 

1Munich/DE, 2Trieste/IT, 3Charlotte/US, 4London/UK, 5Chicago/US, 6Ghent/BE, 7Royal Oak/US 

24.6.3 Carotid artery MRI plaque characterization in patients with suspected acute TIA/ischemic stroke 

J.P. Parmar, C. Kramer, E. Baskurt, J.P. Mugler, R. Walter; presented by K. Hagspiel; Charlottesville/US 

24.6.4 Use of near-infrared refracted spectroscopy for cerebral monitoring during stenting of supra-aortic trunks 

C. Massa Saluzzo, A. Azzaretti, G. Rodolico, F. Di Maria, A. Simoncelli, P. Quaretti; Pavia/IT 

24.6.5 Xper-CT- Flat-detector dacryocystography: A new technique for morphologic 

and functional evaluation of the lacrimal outflow system 

K.E. Wilhelm, S. Lohmaier, M.P. Wattjes, H.H. Schild; Bonn/DE 

24.6.6 A prospective comparison of duplex ultrasonography, Captopril renography, magnetic resonance-angiography 

and computed tomography-angiography in assessing renal artery stenosis 

H. Eklof, H. Ahlstrom, A. Magnusson, L.-G. Andersson, B. Andren, A. Hagg, R. Nyman; Uppsala/SE 

24.6.7 Evaluation of renal in-stent restenosis using multislice computed tomography: 28 patients 

L. Cassagnes, P. Chabrot, E. Dumousset, A. Ravel, E. Lipiecka, J.-M. Garcier, L. Boyer; Clermont-Ferrand/FR 

24.6.8 Magnetic resonance imaging assessment of renal perfusion pre- and post-angioplasty and stenting: initial results 

S.L. Kahn, J.F. Angle, K.D. Hagspiel, F.H. Epstein, S.S. Berr, C.R. Ayers, W.J. Rogers; Charlottesville/US 

24.6.9 Grading of internal carotid artery stenosis: can computed tomography-angiography overcome the confusion? 

R.A. Bucek, S.B. Puchner, M. Reiter, E. Minar, J. Lammer; Vienna/AT 

17:00 - 18:30 


Liver, Lung and kidney intervention Room E 

Chairmen: H. van Overhagen (The Hague/NL), C. Vignali (Pisa/IT) 

24.7.1 Comparison of RECIST and EASL criteria: assessment of treatment response following transarterial embolisation 

or chemoembolisation for unresectable hepatocellular carcinoma 

N. Woodward, A. Papadopolou, J. Williams, T. Meyer, A. Burroughs, N. Davies; London/UK 

24.7.2 Transcatheter arterial chemoembolization for liver metastases in patients with adrenocortical carcinoma 

J. Cazejust, L. Hechelhammer, M. Abdel Rehim, S. Leboulleux, E. Baudin, M. Schlumberger, T. de Baère; Villejuif/FR 

24.7.3 Selective internal radiation therapy with Yttrium90 resin-microspheres 

in extensive metastatic disease of the liver: clinical results 

T.F. Jakobs1, R.-T. Hoffmann1, A. Schmitz1, W. Koch1, K. Tatsch1, M.F. Reiser1, T.K. Helmberger2; 1Munich/DE, 2Lübeck/DE 

24.7.4 Computed tomography follow-up of lung tumors treated by radiofrequency ablation 

J. Palussière1, B. Marcet1, T. de Baère2, A. Ravaud1, M. Kind1, F. Valentin1, M. Asad-Syed1; 1Bordeaux/FR, 2Villejuif/FR 

24.7.5 Computed tomography-guided interstitial single fraction high-dose rate brachytherapy 

of lung tumors: phase-I/II results of a novel technique 

J. Ricke1, M. Pech1, G. Wieners1, K. Mohnike1, R. Ruehl2, N. Peters2, P. Wust2; 1Magdeburg/DE, 2Berlin/DE 

24.7.6 Percutaneous ultrasound-guided radiofrequency ablation of renal tumors: analysis 

of predictors for complications and technical success 

A. Veltri, A. Genovesio, A. Calvo, C. Bussolino Peretto, P. Caggiula, G. Gandini; Turin/IT 

24.7.7 Percutaneous transhepatic biliary drainage for the treatment of bile leak following living donor liver transplantation 

G.-Y. Ko, H.-K. Yoon, K.-B. Sung; Seoul/KR 

24.7.8 Percutaneous radiofrequency ablation of hepatic metastases in patients 

with metastatic breast cancer: medium-term results 

T.F. Jakobs1, R.-T. Hoffmann1, A. Schrader1, T.K. Helmberger2, M.F. Reiser1; 1Munich/DE, 2Lübeck/DE 

24.7.9 Computed tomography-guided percutaneous intervention using a reduced dose radiation: a three-year experience 

B.C. Lucey, J.C. Varghese, J.A. Soto; Boston/US 


Rome 2006 


17:00 - 18:30 


Late Breaking Abstracts Room D 

Chairmen: S.M. Lyon (Melbourne/AU), T.B. Kinney (San Diego, CA/US) 

24.8.1 Transient immunosuppression and oxidative stress after ethanol or radiofrequency-ablation of liver tumors 

J. Kettenbach, C. Schmuckenschlager, M. Ploder, J. Lammer, A. Spittler; Vienna/AT 

24.8.2 In vivo bimodal electric tissue ablation (BETA) creates larger porcine liver ablation zones 

than standard radiofrequency ablation using a LeVeen needle 

C. Dobbins1, S. Wemyss-Holden2, G. Maddern1, J.F. Cockburn2; 1Adelaide/AU, 2Norwich/GB 

24.8.3 Longterm retrieval of modified Günther Tulip Vena Cava Filters - an animal study 

A. Bücker1, F.F. Behrendt1, R. Knüchel-Clarke1, S. Kinzel1, A. Mølgaard-Nielsen4, R. W. Günther1; 1Aachen/DE, 2Bjaeverskov/DK 

24.8.4 Catheter and magnetically guided and detached ferromagnetic nanoparticle filaments 

with heat-induced particle release 

A. H. Mahnken, M. Baumann, M. Floren, R. W. Günther, D. Müller-Schulte, T. Schmitz-Rode; 

Aachen/DE 

24.8.5 Chemoembolization of unresectable hepatocellular carcinoma with doxorubicin loaded microspheres: First results 

A. Stadler, F. Lomoschitz, R. E. Schernthaner, J. Kettenbach, I. Katzler, J. Lammer; Vienna/AT 

24.8.6 Histopathology of tissue extracted on the probe after radiofrequency ablation 

of liver malignancy can predict local progression: initial results 

C. T. Sofocleous1, R. G. Nascimento1, D. Klimstra2, L. Petrovic2, M. Gonen3, L. Brody1, A. Covey1, S. B. Solomon1, G. Getrajdman1, K. T. Brown1; New York, NY/US 

24.8.7 An economic evaluation of uterine artery EMbolization versus hysterectoMY in the treatment of symptomatic uter 

ine fibroids: results from the randomized EMMY-trial. 

N.A. Volkers1, W. J. Hehenkamp2, P. M. Smit2, E. Birnie3, W. M. Ankum2, J. A. Reekers1; Amsterdam/NL 

Monday, September 11, 2006 

08:30 - 09:45 


Carotid Stenting Room B 

Chairmen: P. Gaines (Sheffield/UK), L. Stockx (Genk/BE) 

25.1 Patient selection & preprocedure imaging 

S. Macdonald; Glasgow/UK 

25.2 Device selection 

A. Cremonesi; Cotignola. RA/IT 

25.3 Tips to prevent complications 

P. Gaines; Sheffield/UK 

25.4 Endarterectomy versus stenting : Is the pendulum swinging to stents? 

M. Thompson; London/UK 

08:30 - 09:45 


IR in Liver Transplantation Room F 

Chairmen: J.I. Bilbao (Pamplona/ES), Z.J. Haskal (New York, NY/US) 

26.1 HCC: Biopsy or imaging diagnosis 

J. Bruix; Barcelona/ES 

26.2 HCC management while awaiting transplant 

A. Veltri; Turin/IT 

26.3 Management of post transplant biliary complications 

J.B. Karani; London/US 

26.4 Vascular complications post transplant 

Z.J. Haskal; New York, NY/US 

C RSE 

47


08:30 - 09:45 



Chairmen: A.C. Roberts (La Jolla, CA/US), D. Vorwerk (Ingolstadt/DE) 

27.1 Life style adaptation and medical therapy are an effective form of treatment 

D.L. Clement; Ghent/BE 

27.2 Balloon angioplasty: Where does it fit? 

S. Müller-Hülsbeck; Kiel/DE 

27.3 Implications of TASC 2 

L. Norgren; Lund/SE 

27.4 Does subintimal angioplasty have a role? 

A. Bolia; Leicester/UK 

08:30 - 09:45 


Non Vascular Room C 

M.J. Lee (Dublin/IE), A.F. Watkinson (Exeter Devon/UK) 

09:45 - 10:15 


09:45 - 10:15 


Common findings 1: Documentation and reporting/Informed consent process 



10:15 - 11:30 

Session 29 Interactive Case Session 

Basic vascular diagnosis Room B 

Organisers: J.A. Kaufman (Lake Oswego, OR/US), M.J. Lee (Dublin/IE) 

10:15 - 11:30 


RF Ablation: Clinical Results Aula Magna 

Chairmen: R. Gandini (Rome/IT), P.R. Mueller; Boston, MA/US 

30.1 Primary liver cancer 

M. Bezzi; Rome/IT 

30.2 Radiofrequnecy of liver metastasis : clinical results 

T. de Baere; Villejuif/FR 

30.3 Renal cancer 

M.A. Farrell; Rochester/US 

30.4 Lung cancer 

R. Lencioni; Pisa/IT 

10:15 - 11:30 


IR/OR Suite of the Future Room F 

Chairmen: R.W. Günther (Aachen/DE), M.D. Dake (Charlottesville, VA/US) 

31.1 Structure & design 

J. Lammer; Vienna/AT 

31.2 Imaging modality integration: MR, CT, US CT/PET 

M.D. Dake; Virginia/US 

31.3 Who will use it? 

A. Adam; London/UK 



Rome 2006 

11:45 - 12:15 



Terumo and Biocompatibles 

Interventional Oncology - Drug Eluting Beads, the future Aula Magna 

Chairman: J. Lammer; Vienna/AT 

Combined Precision TACE and RF ablation in hepatocellular carcinoma treatment 


Treatment of lung and colon liver metastases with drug eluting beads 

T. Vogl; Frankfurt a. Main/DE 

Boston Scientific delivering what's next in uterine fibroid embolisation… Room B 

Predictors of clinical success in UFE: Why complete fibroid infarction is key 

and how to achieve it 


BayerHealthcare 

Advances in thrombolytic therapy: a focus on alfimeprase Room F 

Chairman: G. Tepe, Tübingen/DE 

Alfimeprase: a recombinant direct-acting fibrinolytic 

S. Deitcher; San Carlos, CA/US 

NAPA: novel arterial perfusion with alfimeprase, a multicentre phase II study 

B.T. Katzen; Miami, FL/US 

12:30 - 13:30 

Session 33 Foundation Course 

SFA Angioplasty Aula Magna 

Chairman: D.A. Kelekis; Athens/GR 

33.1 Antegrade Access 

J.H. Peregrin; Prague/CZ 

33.2 Retrograde to antegrade access 

D. Tsetis; Heraklion/GR 

33.3 Popliteal Access 

S. Yilmaz; Antalya/TR 

33.4 Crossing the lesion and PTA 

D. Vorwerk; Ingolstadt/DE 

33.5 When to stop or stent 

J.-P. Beregi; Lille/FR 

C RSE 

49


13:45 - 14:15 


W.L. Gore & Ass. 

Title: to be announced Aula Magna 

Edward Lifesciences 

New updates of the SFA treatment. 

The RESILIENT trial & the Edwards Lifestent Room B 

Chairman: J. Lammer; Vienna/AT 

Endovascular treatments in the SFA & critical limb ischemia: what do we know? 

J. van den Berg; Lugano/CH 

Update on the RESILIENT trial: 12 month data and quality of life measures, 

what do those new treatment options bring to the patient? 

B.T. Katzen; Miami, FL/US 

GE Healthcare 

An international multidisciplinary approach to formulating strategies 

for preventing CIN Room F 

Chairman: A. Adam; London/UK 

Chairman's welcome and introduction 

A. Adam; London/UK 

CIN consensus statements: practical guidance in managing the at risk patient 

C. Becker; Munich/DE 

Summary and discussion 

14:30 - 15:15 

Session 35 Josef Roesch Lecture 

Drugs and Devices - Challenges and Opportunities 

for Interventional Radiology Aula Magna 

L. Machan; Vancouver/CA 

Laudation: M. Lee; Dublin/IE 

17:00 - 18:00 


15:15 - 15:45 


15:45 - 17:00 

General Assembly Aula Magna 

(for members only) 

37.1 How I do chemoembolisation? Aula Magna 

R. Golfieri (Bologna/IT), J. Golzarian (Iowa City/US) 

37.2 Venous insufficiency: Clinical appraisal and Doppler examination Room E 

A. Mavor (Leeds/UK), R.L. Worthington-Kirsch (Philadelphia/US), 

D.J. West (Stroke on Trent, Staffs/UK), M. Weston (Leeds/UK) 

37.3 Endovenous ablation: Sclerotherapy, laser and RF Room H 

S. Kundu (Scarborough/CA), L. Machan (Vancouver/CA) 

37.4 Trauma intervention: Getting started Room B 

S.J. Sclafani (Brooklyn/US), W. Jaschke (Innsbruck/AT) 

37.5 EVAR advanced Room D 

H.T. Kobeiter (Créteil/FR), B.T. Katzen (Miami/US) 

37.6 Drugs used in arterial intervention Room C 

C.W. Kopp (Vienna/AT), H.-J. Wagner (Marburg/DE) 

37.7 Subintimal angioplasty: Tips for success Room F 

J.A. Reekers (Amsterdam/NL), A. Bolia (Leicester/UK) 

37.8 Venous malformation: IR treatment Room I 

P.C. Rowlands (Liverpool/UK), M. Ryan (Dublin/IE) 

37.9 Dialysis fistula Room G 

L.A. Turmel-Rodrigues (Tours/FR), M.A. Funovics (Vienna/AT) 


Rome 2006 


17:00 - 18:30 


Basic 2: Radiofrequency Ablation WS Room 1 



Tuesday, September 12, 2006 

08:30 - 09:45 


Renal Artery Intervention Room F 

Chairmen: J.H. Peregrin (Prague/CZ), T.A. Sos (New York, NY/US) 

38.1 Who should undergo renal artery intervention? 

W.P. Mali; Utrecht/NL 

38.2 Technique - Tips for success 

L. Boyer; Clermont-Ferrand/IL 

38.3 Success & patency rates 

M. Sapoval; Paris/FR 

38.4 Medical Therapy of renal insufficiency pre/post intervention 

P. Conlon; Dublin/IE 

08:30 - 09:45 


Thoracic Stent Grafts Room B 

Chairmen: M. Maynar (S/C Tenerife/ES), M. Thompson (London/UK) 

39.1 Preprocedure imaging & patient selection for TAA 

R.A. Morgan; London/UK 

39.2 Tips for a successful procedure 

H. Rousseau; Toulouse/FR 

39.3 Results, morbidity and mortality 

J. Buth; Eindhoven/NL 

39.4 Stent grafts inasymptomatic dissections/INSTEAD trial 

C. Nienaber; Rostock/DE 

08:30 - 09:45 



Chairmen: J. Lammer (Vienna/AT), B.T. Katzen (Miami, FL/US) 

40.1 Stent vs PTA: What is the evidence 

J. Lammer; Vienna/AT 

40.2 Covered stents: Has their time come? 

J.-P. Beregi; Lille/FR 

40.3 Emerging Technologies 

T. Jahnke; Kiel/DE 

40.4 What is the role of fem- pop bypass? 

C. Kelly; Dublin/IE 

08:30 - 09:45 


Vascular Room C 

A.A. Nicholson; Leeds/UK, N. McEniff, Dublin/IE 

09:45 - 10:15 



51


09:45 - 10:15 

Good Clinical Practice Research Awareness Programme 5 Room I 

Common findings 2: Protocol deviations/Device accountability 



10:15 - 11:30 


AAA Stent Grafts Aula Magna 

Chairmen: H. Rousseau (Toulouse/FR), R.G. McWilliams (Liverpool/UK) 

42.1 Implications of EVAR and DREAM trials 

R.M. Greenhalgh; London/UK 

42.2 Will emergency EVAR replace open surgery? 

J. Buth; Eindhoven/NL 

42.3 Surveillance and when to treat type 2 endoleaks 

G. Gilling-Smith; Liverpool/UK 

42.4 How to treat type 2 endoleaks 

R.G. McWilliams; Liverpool/UK 

10:15 - 11:30 


Iliofemoral DVT Room B 

Chairmen: Y. Hoogeveen (Nijmegen/NL), S. Kee (Stanford, CA/US) 

43.1 Limitations of current management strategies 

K.R. Thomson; Melbourne/AU 

43.2 Thrombolysis 

S. Kee; Los Angeles, CA/US 

43.3 Mechanical thrombectomy 

G.J. O'Sullivan; Galway/IE 

10:15 - 11:30 


Controversies in Non-Vascular IR Room F 

Chairman: A. Hatzidakis (Iraklion/GR) 

44.1a Cutting needles are all you need for percutaneous biopsy ? - Pro: Cutting needles 

M.J. Lee; Dublin/IE 

44.1b Cutting needles are all you need for percutaneous biopsy ? - Pro: Fine Needles 

T. Petsas; Patras/GR 

44.2a TIPS or Endoscopic treatment for variceal rebleeding ? - Pro: TIPS 

G.M. Richter; Heidelberg/DE 

44.2b TIPS or Endoscopic treatment for variceal rebleeding? - Pro: Endoscopic treatment 

F.E. Murray; Dublin/IE 

44.3a Pro: Is Colonic stenting before colon resection necessary? 

C.L. Zollikofer; Winterthur/CH 

44.3b Contra: Is Colonic stenting before colon resection necessary? 

R. Tersigni; Rome/IT 

11:30 - 12:00 




Rome 2006 


12:00 - 13:00 


Film Interpretation Panel Aula Magna 

Organiser: A.A. Nicholson, Leeds/UK 

Scorer: A. Watkinson, Exeter/UK 

Superheroes: Bad Guys: 

J.I. Bilbao, Pamplona/ES W. Cwikiel, Ann Arbor, MI/US 

P. Gaines, Sheffield/UK A. Hatzidakis, Iraklion/GR 

I. Pinto Pabón, Madrid/ES R. Lencioni, Pisa/IT 

O.M. van Delden, Amsterdam/NL G.J. O’Sullivan, Galway/IE 

13:15 - 13:45 


Boston Scientific delivering what's next in carotid artery stenting… Aula Magna 

How do stent and embolic protection designs influence clinical outcomes 

in carotid artery stenting? 

M. Bosiers; Dendermonde/BE 

Bracco/Schering/Guerbet 

Focus on contrast-induced nephropathy Room B 

Selection and use of contrast media in patients at risk for CIN 

H.S. Thomsen; Copenhagen/DK 

Recommendations for prevention of CIN and management of patients at risk 

B. Barrett; St. John's, NF/CA 

Cordis 

Evidence in Lower Limbs Room F 

Chairman: S.H. Duda; Berlin/DE 

Stenting in SFA 


Cypher in BTK, encouraging preliminary results 


14:00 - 15:15 


Morbidity and Mortality Conference /Vascular Aula Magna 

Chairmen: K.A. Hausegger (Klagenfurt/AT), M.J. Lee (Dublin/IE) 

Devil's advocate: G. Fraedrich, Innsbruck/AT 

Panel: 

K.H. Hauenstein, Rostock/DE 

A.A. Nicholson, Leeds/UK 

T. Pfammatter, Zürich/CH 

M.R. Sapoval, Paris/FR 

L. Stockx, Genk/BE 

15:15 - 15:45 


15:30 - 17:00 


Advanced 2: Radiofrequency Ablation WS Room 1 



53


15:45 - 16:45 


48.1 Carotid stenting: Getting started Aula Magna 

S. Macdonald (Glasgow/UK), B.E. Cil (Ankara/TR) 

48.2 Closure device: When, how and what device Room C 

S. Müller-Hülsbeck (Kiel/DE), S. Lyon (Victoria/AU) 

48.3 Advanced venous acces Room I 

A.F. Watkinson (Exeter Devon/UK), S. Trerotola (Philadelphia/US) 

48.4 Post Partum haemorrhage: Prevention and treatment Room G 

A.C. Roberts (La Jolla/US), H.T. Abada (Cergy-Pontoise/FR) 

48.5 Lung and renal RF Room B 

J. Palussière (Bordeaux/FR), D. Dupuy (Providence, RI/US) 

48.6 Thoracic stenting: How I do it Room H 

R.A. Morgan (London/UK), M.D. Dake (Charlottesville, VA/US) 

48.7 EVAR: Patient selection, technique and follow-up protocols Room F 

C. Vignali (Pisa/IT), M. Szczerbo-Trojanowska (Lublin/PL) 

48.8 Intervention in severe acute pancreatitis Room D 

O. Akhan (Ankara/TR), P.C. Rowlands (Liverpool/UK) 

48.9 IVC Filters Room E 

T.B. Kinney (San Diego, CA/US), M.J. Lee (Dublin/IE) 

17:00 - 18:30 


Liver Tumors (vascular therapies) Room C 

Chairmen: B. Wood (Bethesda, MD/US), M. Okazaki (Fukuoaka/JP) 


49.1.1 Selective internal radiation therapy in patients with advanced hepatocellular carcinoma 

A. Martinez de la Cuesta, J. Bilbao, B. Sangro, J. Boan, J. Rodriguez, J. Noguera; Pamplona/ES 

49.1.2 Treatment of extensive metastatic liver disease with transarterial, 

intrahepatic administration of Yttrium90 microspheres: toxicity assessment 

T.F. Jakobs 1, R.-T. Hoffmann 1, A. Schmitz 1, K. Tatsch 1, W. Koch 1, T.K. Helmberger 2, M.F. Reiser 1; 

1Munich/DE, 2Lübeck/DE 

49.1.3 Sequential tanscatheter arterial chemoembolization and portal vein embolization 

before major hepatectomy for patients with hepatocellular carcinoma 

D.C. Madoff, E.K. Abdalla, M.J. Wallace, R. Murthy, K. Ahrar, S. Gupta, S.H. Wei, M.E. Hicks, J.-.N. Vauthey; Houston/US 

49.1.4 Treatment of unresectable hepatocellular carcinoma using intra-arterial Yttrium-90: long-term follow-up 

B. Atassi, R. Lewandowski, L. Kulik, M.F. Mulcahy, R.A. Omary, R. Salem; Chicago/US 

49.1.5 Transarterial chemoembolization of neuroendocrine hepatic metastases using drug-eluting beads 

C. Teriitehau, T. de Baère, M. Abdel Rehim, F. Deschamps; Villejuif/FR 

49.1.6 Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma 

with inferior vena cava and right atrium tumors 

M.-C. Chern, V.P. Chuang, T.-I. Cheng; Taipei/TW 

49.1.7 Preoperative chemoembolization in Patients with hepatocellular carcinoma undergoing 

liver transplantation: influence of emergent versus elective procedures on patient survival 

and tumor recurrence rate. 

E.M. Walser, A.H. Stockland, R. Paz, J.M. McKinney, G.R. May; Jacksonville/US 

49.1.8 Hepatocellular carcinoma chemoembolization with DC beads in 42 patients. Safety and efficacy 

K. Malagari, E. Alexopoulou, K. Chatzimichail, T. Spyridopoulos, G. Economou, D. Letsou, V. Vergadis, 

D. Antonopoulos, D.A. Kelekis, A. Gouliamos; Athens/GR 

49.1.9 Radioembolism (Ittrium 90) of hepatic liver mets. Preliminary experience 

R. Cianni, A. Satarelli, E. Notarianni, M. Iozzino, M. Coniglio; Latina/IT 

49.1.10 "Best of SIR" - A radiogenomic analysis to identify imaging phenotypes associated 

with drug response gene expression programs in HCC 

M.D. Kuo, J. Gollub, C.B. Sirlin, C. Ooi; San Diego, CA/US 


Rome 2006 


17:00 - 18:30 


Aortic stent graft (3) Room B 

Chairmen: J.-M. Bartoli (Marseille/FR), B.T. Katzen (Miami, FL/US) 

49.2.1 Proximal aneurysm neck expansion following endovascular aneurysm repair: a cause for graft failure? 

R.K. Fisher, R.E. Williams, J. Rose, R.W. Jackson, S.J. Holtham, M.G. Wyatt; Newcastle upon Tyne/UK 

49.2.2 Endovascular repair of traumatic rupture of the aortic isthmus: medium-term results 

O. Cosín, H. Rousseau, B. Marcheix, C. Dambrin, C. Cron, M. Bennaceur, V. Chabbert, P. Otal, F. Joffre; Toulouse/FR 

49.2.3 Endovascular repair of thoracic aortic lesions with Medtronic's Talent and Valiant thoracic endografts 

F. Numan, B. Sönmez, H. Arbatli, K. Bozkurt, M. Cantasdemir, M. Özbayrak, A. Ömeroglu, A. Mansur; Istanbul/TR 

49.2.4 Abdominal aortic aneurysms secrete interleukin-6 into the circulation 

J. Dawson, G. Cockerill, E. Choke, I. Loftus, R. Morgan, A.-M. Belli, M.M. Thompson; London/UK 

49.2.5 Visualization of the artery of Adamkiewicz at electrocardiography-gated 

multidetector row helical computed tomography in patients with Stanford type A aortic dissection 

A. Kovács, T. Sommer, W. Schiller, M. Hackenbroch, H.H. Schild, S. Flacke; Bonn/DE 

49.2.6 Abdominal aortic aneurysm in octogenarians: a single-centre experience 

C. Setacci, G. de Donato, G. Palasciano, M. Giubbolini, E. Chisci, A. Cappelli, M. Pieraccini; Siena/IT 

49.2.7 Embolization of the internal iliac artery. Cost effectiveness of two different techniques 

O. Pellerin, T. Caruba, L. Novelli, B. Beyssen, J. Pineau, M. Sapoval; Paris/FR 

49.2.8 Suprarenal fixation promotes reduction in sac diameter after endovascular aneurysm repair 

R.E. Williams, R.K. Fisher, J. Rose, R.W. Jackson, M.G. Wyatt, S.J. Holtham, M. Jackson; Newcastle upon Tyne/UK 

49.2.9 Endoleak, secondary intervention and mortality of endovascular aneurysm repair are improving with time 

R.D. Sayers, S. Franks, M. Bown, A. Sutton, G. Fishwick; Leicester/UK 

17:00 - 18:30 


Peripheral Angioplasty (2) Room F 

Chairmen: R. Gandini (Rome/IT), P. Kennedy (Belfast/UK) 

49.3.1 European multicentric prospective study evaluating clinical performance and 

cost effectiveness of Hemobahn/Viabahn endoprostheses versus by-pass graft surgery 

in the correction of femoropopliteal lesions (Hemobahn CIRSE study) 

H. Rousseau, O. Cosín, P. Otal; Toulouse/FR 

49.3.2 Safety and efficacy of the Express® vascular LD stent in the treatment of iliac artery lesions: the MELODIE experience 

L. Stockx; Genk/BE 

49.3.3 Sirolimus for below-the-knee lesions with critical ischemia: medium-term results of the "Siro-BTK study" 

P. Commeau, P.T. Barragan, P.O. Roquebert; Ollioules/FR 

49.3.4 Clinical outcome of patients surviving more than three years after subintimal angioplasty 

M. Akesson, L. Riva, K. Ivancev, P. Uher, A. Lundell, M. Malina; Malmoe/SE 

49.3.5 Use of a self-expanding nitinol stent (Absolute) in the treatment of atherosclerotic occlusive disease 

of the superficial femoral artery 

H. Schroe1, F. Vermassen2, P.P. Goffette3, G. Lauwers1, W. Lansink1, L. Stockx1, J. Deroose2, C. Randon2, S. Vercauteren1; 1Genk/BE, 2Ghent/BE, 3Brussels/BE 

49.3.6 Long-term results of cutting balloon angioplasty for critical limb ischemia 

T.O. McNamara, A. Gomes, C. Anaya, V. Sigalov, B.J. Quinn; Los Angeles/US 

49.3.7 Stents in infrapopliteal arteries as a bail-out procedure: six-month follow-up results 

J.H. Peregrin, S. Šmírová; Prague/CZ 

49.3.8 Initial and intermediate term results of use of cutting balloon for claudication 

T.O. McNamara, B.J. Quinn, C. Anaya, A. Gomes, V. Sigalov; Los Angeles/US 

49.3.9 Drug-coated balloon angioplasty prevents restenosis.Six-month angiographic follow-up of the Thunder trial 

G. Tepe1, T. Zeller2, T. Albrecht3, S.H. Duda3, U. Speck3; 1Tübingen/DE, 2Bad Krotzingen/DE, 3Berlin/DE 

C RSE 

55


17:00 - 18:30 


Liver tumor ablation Aula Magna 

Chairmen: A. Denys (Lausanne/CH), R. Lencioni (Pisa/IT) 


49.4.1 Radiofrequency thermal ablation versus percutaneous ethanol injection for "early" hepatocellular carcinoma: 

final results of a randomized controlled study 

A. Veltri, P. Moretto, P. Sacchetto, F. Brunello, E. Pagano, G. Gandini; Turin/IT 

49.4.2 Computed tomography-guided brachytherapy versus laser ablation of colorectal liver metastases: 

a matched-pair, same patient analysis 

J. Ricke1, M. Pech1, G. Wieners1, R. Ruehl2, K. Mohnike1, P. Wust2; 1Magdeburg/DE, 2Berlin/DE 

49.4.3 Percutaneous ethanol injection of medium and large hepatomas using a multi-pronged needle: early experience 

C.-S. Ho, J. Kachura, K. Tan, R. Beecroft, D. Grant, P. Greig, M. Sherman, F. Wong; Toronto/CA 

49.4.4 Modified radiofrequency ablation technique creates larger ablation zones than standard radiofrequency ablation 

in ex-vivo liver using a proprietary expansile needle 

J.F. Cockburn, S. Wemyss-Holden; Norwich/UK 

49.4.5 Computed tomography-guided radiofrequency ablation of hepatic and non-hepatic malignancies. 

A six-year experience 

S. Mylona, L. Thanos, M. Gravanis, E. Stroumpouli, M.-S. Grammenou-Pomoni, N. Batakis; Athens/GR 

49.4.6 Thermal ablation of hepatocellular carcinoma before liver transplantation: patient outcome and tumor necrosis 

in explanted livers 

C.-S. Li, R.S. Arellano, D.A. Gervais, P.R. Mueller; Boston/US 

49.4.7 Is it possible to identify markers of inadequate response to percutaneous ethanol injection 

and radiofrequency thermal-ablation of suprarenal adenomas in secondary hypertension 

due to hyperaldosteronism? 

P.A. Almeida, G. Pêgo, P. Ribeiro, F. Caseiro-Alves, L. Providência; Coimbra/PT 

49.4.8 Radiofrequency ablation of liver metastases from colorectal cancer: medium-term results in 122 patients 

A. Veltri, P. Sacchetto, P. Caggiula, C. Bussolino Peretto, M. Cassinis, G. Gandini; Turin/IT 

49.4.9 In-vivo radiofrequency liver thermoablation under real-time magnetic resonance temperature monitoring 

C.D. Becker, S. Terraz, L. Rubbia-Brandt, M. Ivancevic; Geneva/CH 

49.4.10 "Best of SIR" - Radiofrequency ablation of small < 4 cm hereditary or familial kidney tumors: 

long term results > 5 years 

B.J. Wood, J. Locklin, Z. Neeman, P. Choyke, J. Coleman, M. Walther; Bethesda, MD/US 

17:00 - 18:30 


Fibroid embolization and other gynecologic intervention Room G 

Chairmen: J. Golzarian (Iowa City/US), P.N Lohle (Tilburg/NL) 

49.5.1 Sexuality after uterine artery embolisation and hysterectomy in the treatment of uterine fibroids: 

A randomized comparison (EMMY-trial) 

N.A. Volkers, W.J. Hehenkamp; Amsterdam/NL 

49.5.2 Ovarian Artery Embolization for Symptomatic Uterine Leimyomata 

H.S. Kim, B.E. Paxton; Stevenson/US 

49.5.3 Microcoil embolization of patent uterine-ovarian anastomosis 

H.S. Kim, B.E. Paxton; Stevenson/US 

49.5.4 Pregnancy after uterine fibroid embolization - one centre data 

R. Pietura, M. Janczarek, M. Szczerbo-Trojanowska; Lublin/PL 

49.5.5 Ovarian damage after uterine artery embolisation: a randomised comparison with hysterectomy 

N.A. Volkers, W.J. Hehenkamp; Amsterdam/NL 

49.5.6 Uterine artery embolization (UAE) versus hysterectomy: comparison of clinical outcome 

and quality of life after 12 months. 

N.A. Volkers; Amsterdam/NL 

49.5.7 Devascularization of fibroids on early contrast-enhanced magnetic resonance 

after uterine artery embolization: infarction rate determines clinical outcome and probability 

of re-intervention. Results of a prospective study 

T.J. Kroencke, C. Scheurig, T. Schink, E. Zimmermann, C. Kluner, B. Hamm; Berlin/DE 

49.5.8 Transarterial embolization for massive vaginal bleeding: 

importance of the round ligament artery as a potential bleeder 

J.H. Joh, B.H. Yi, S.J. Park, J.S. Park, H.K. Lee; Bucheon/KR 

49.5.9 Endovascular therapy of ectopic tubal pregnancies 

R.P. Nechifor, B. Dorobat, G. Iana, G. Meszaros, A. Pavel, V. Horhoianu; Bucharest/RO

Rome 2006 


17:00 - 18:30 


Embolization Room I 

Chairmen: D. Krause (Dijon/FR), R. Tanaka (Iwate/JP) 

49.6.1 Water-soluble polyvinyl alcohol in the renal artery of pigs: 

radiological-pathological evaluation for temporary arterial occlusion 

Y. Shomura1, N. Tanigawa1, T. Tokuda1, S. Kariya1, H. Kojima1, A. Komemushi1, S. Sawada1, M. Shibutani2, S. Wakimoto2; 1Hirakata/JP, 2Ibaraki/JP 

49.6.2 Necrosis induced by acetic acid release from sodium acrylate polyvinyl-microspheres in sheep liver embolization 

M.T. Baylatry1, M. Wassef1, R. Chapot2, D. Labarre3, A. Laurent1; 1Paris/FR, 2Limoges/FR, 3Châtenay-Malabry/FR 

49.6.3 A new composite gel for embolization: evaluation in an animal model 

A. Seron1, R. Chapot2, D. Labarre3, L. Moine3, G. Guiffant1, J. Labsky4, A. Laurent1; 1Paris/FR, 

2Limoges/FR, 3Châtenay Malabry/FR, 4Prague/CZ 

49.6.4 Magnetic resonance-detectable microspheres for embolization: 

biocompatibility and detectability in sheep uterus at three weeks and seven months 

J. Namur1, J.P. Pelage2, M. Wassef2, R. Chapot3, A. Laurent1; 1Jouy-en-Josas/FR, 2Paris/FR, 3Limoges/FR 

49.6.5 Ibuprofen-loaded embolisation microspheres: quantification of their anti-inflammatory effect 

in a sheep uterus model 

J.P. Pelage1, J. Namur2, M. Wassef2, E. Velzenberger2, I. Schwartz-Cornil3, A. Laurent2; 1Boulogne sur Seine/FR, 

2Paris/FR, 3Jouy en Josas/FR 

49.6.6 Lung radiofrequency ablation: in-vivo experimental study with perfused multi-tined electrodes 

L. Crocetti, E. Bozzi, A. Sbrana, R. Lencioni; Pisa/IT 

49.6.7 Endovascular therapy of visceral artery aneurysms 

C.A. Lottersberger, A. Dessl, T. Martini, A. Chemelli, W.R. Jaschke, P. Waldenberger; Innsbruck/AT 

49.6.8 Emergent transcatheter embolization of traumatic mesenteric hemorrhage 

P.P. Goffette, P.F. Laterre, X. Wittebole, J.-F. Gigot; Brussels/BE 

49.6.9 Diagnostic angiography and interventional approach for gastrointestinal bleeding 

N. Kono1, A. Furukawa1, M. Yamasaki1, T. Tanaka1, N. Nitta1, R. Takazakura1, S. Kanasaki2, M. Takahashi1, K. Murata1, T. Sakamoto3; 1Otsu/JP, 2Kyoto/JP, 3Koka/JP 

17:00 - 18:30 


Peripheral Angioplasty (3) Room E 

Chairmen: T. Jahnke (Kiel/DE), M. Morucci (Rome/IT) 

49.7.1 Acute results of 4-F sheath-compatible self-expanding nitinol stents for the treatment 

of infragenicular arteries following unsuccessful balloon-angioplasty 

G. Tepe1, T. Zeller2, S. Heller1, J. Wiskirchen1, S.H. Duda3, C.D. Claussen1; 1Tübingen/DE, 2Bad Krotzingen/DE, 

3Berlin/DE 

49.7.2 Endovascular therapy in Takayasu's arteritis 

A. Memis1, M. Parildar1, K. Aksu1, G. Demirpolat2, E. Doganavsargil1; 1Izmir/TR, 2Kahramanmaras/TR 

49.7.3 Superficial femoral artery subintimal angioplasty: our experience in 148 patients 

L. Maresca, R. Gandini, M. Stefanini, M. Chiocchi, A. Spinelli, G. Simonetti; Rome/IT 

49.7.4 Leg reconstruction by reversed saphenous flap: role of interventional radiology 

F. Perona, P. Stradiotti, G. Castellazzi, S. Zaid, G. Giordano, G. Cornalba; Milan/IT 

49.7.5 Cutting-balloon angioplasty versus conventional balloon angioplasty in short femoro-popliteal arterial stenoses 

R. Iezzi, A.R. Cotroneo, F. Quinto, R. Esposito, M. Santoro, D. Gabrielli, M.L. Storto; Chieti/IT 

49.7.6 Prospective evaluation of mortality and morbidity in patients treated by PTA for atheromatous peripheral lesions. 

J.-P. Beregi1, J.-C. Crombez1, J.-B. Raffin2, G. Deklunder1, J.-L. Dehaene1, M.-H. Catteau for the FRED network3; 1Lille/FR, 2Bois Bernard/FR, 3Arras/FR 

49.7.7 Comparison of rotational thrombectomy and ultrasound-enhanced thrombolysis in acute limb ischemia 

C. Wissgott, H.J. Steinkamp; Berlin/DE 

49.7.8 Rapid-exchange monorail technique enhances technical success of percutaneous transluminal angioplasty 

in patients with femoropopliteal occlusive disease 

T. Jahnke1, J. Michalek1, P. Schäfer1, F. Schäfer1, N. Charalambous1, S. Müller-Hülsbeck1, M. Sapoval2; 1Kiel/DE, 

2Paris/FR 

49.7.9 Long-term results of hybrid (combined open vascular and endovascular) interventions 

for the treatment of chronic lower limb ischemia 

M. Kalinowski, S. von Rönn, J. Geks, K.J. Klose, H.-J. Wagner; Marburg/DE 


57


Wednesday, September 13, 2006 

08:30 - 09:45 


Vascular Imaging 1: Imaging of the Legs Room F 

Chairmen: T. Lupattelli (Perugia/IT), M.A. Bettmann (Winston Salem, NC/US) 

50.1 Tips to improve MRA 

C.M. Loewe; Vienna/AT 

50.2 Tips to improve CTA 

C. Catalano; Rome/IT 

50.3 Doppler sonography: tips in difficult patients/diseases 

J.V. Patel; Leeds/UK 

08:30 - 09:45 


New IR therapies for Cancer Room B 

Chairmen: T. De Baere (Villejuif/FR), J. Tacke (Passau/DE) 

51.1 Principles of cancer treatment 

P.J. Johnson; Birmingham/UK 

51.2 Drug Eluting Particles 

J. Bruix; Barcelona/ES 

51.3 Interstitial radiotherapy 

J. Bilbao; Pamplona/ES 

51.4 Combined therapies 


08:30 - 09:45 


Uterine Fibroid Embolisation Aula Magna 

Chairmen: L.E.H. Lampmann (Tilburg/NL), G.M. Richter (Heidelberg/DE) 

52.1 Work up & embolization technique 

W.J. Walker; Surrey/UK 

52.2 Post procedure follow up and imaging 

J.-P.P. Pelage; Boulogne/FR 

52.3 Long term results & fertility issues 

J.B. Spies; Washington, DC/US 

09:45 - 10:15 


09:45 - 10:15 


Common findings 3: Major adverse events vs. serious adverse events 



10:15 - 11:30 


Vascular Imaging 2: Plaque Imaging Room B 

Chairmen: E. Minar (Vienna/AT), L. Inglese (Milan/IT) 

53.1 Clinical importance of Assessing Plaque Vulnerability. Role of Imaging 

S. Fabiano; Rome/IT, G. Simonetti; Rome/IT 

53.2 MR imaging 

P.C. Douek; Lyon/FR 

53.3 Endovascular Ultrasound 

H.I. Manninen; Kuopio/FI 

53.4 Optical Coherence Imaging 

O.A. Meissner; Munich/DE 


Rome 2006 


10:15 - 11:30 


Controversies in Vascular IR Aula Magna 

Chairman: E. Brountzos (Athens/GR) 

54.1a Pro: Stenting of the SFA is the future 

M. Sapoval; Paris/FR 

54.1b Contra: Stenting of the SFA is the future 


54.2a Pro: Renal Artery stenting is indicated for hypertensive patients 

L. Stockx; Genk/BE 

54.2b Con: Renal Artery stenting is indicated for hypertensive patients 

W.P. Mali; Utrecht/NL 

54.3a Pro: Fertility is preserved after UAE 

J.B. Spies; Washington, DC/US 

54.3b Contra: Fertility is preserved after UAE 

J.A. Reekers; Amsterdam/NL 

10:15 - 11:30 


Radiation Protection for Interventional Radiologists Room F 

Chairman: G. Bartal (Kfar-Saba/IL), L. Tipaldi (Rome/IT) 

55.1 Doses to the eye in the IR suite 

Z.J. Haskal; New York, NY/US 

55.2 Strategies to reduce doses in the IR suite 

E. Vano; Madrid/ES 

55.3 Flat panel digital technology in interventional Radiology 

H. Rousseau; Toulouse/FR 

11:30 - 12:00 


12:00 - 13:00 


56.1 Chemoembolisation: Tips and tricks Aula Magna 

D. Gasparini, Udine/I, A.J. Roche (Villejuif/FR) 

56.2 Abcess drainage: How I do it Room I 

O. Akhan (Ankara/TR), M.A. Funovics (Vienna/AT) 

56.3 Below knee angioplasty: How I do it Room F 

D. Karnabatidis (Patras/GR), T. Rand (Vienna/AT) 

56.4 Cardiac Imaging (Coronory CTA and MR myocardium) Room G 

R. Fattori (Bologna/IT), C.M. Loewe (Vienna/AT) 

56.5 Follow up and assessment of tumour post IR therapy Room B 

D. Cioni (Pisa/IT), T. De Baere (Villejuif/FR) 

56.6 DVT thrombolysis and mechanical thrombectomy Room C 

S. Kee (Stanford/US), G.J. O'Sullivan (Galway/IE) 

56.7 Basic genitourinary intervention Room H 

E. Brountzos (Athens/GR), K. Malagari (Athens/GR) 

56.8 EVAR in ruptured AAA Room E 

T. Pfammatter (Zürich/CH), to be announced 

56.9 Venous angioplasty and stenting Room D 

J. Tacke (Passau/DE), P. Marcy (Nice/FR) 

C RSE 

59


EPOS Poster Exhibition First Floor 


P1 What is the most important factor for the successful interventional embolization of gastrointestinal hemorrhages? 

A logistic regression analysis 

O. Ikeda, Y. Nakasone, Y. Yamashita, Y. Shigematsu, K. Kudoh, K. Harada, I. Yoshinaka, N. Takada, J. Nasu; 

Kumamoto/JP 

P2 A newly developed biodegradable stent for the gastrointestinal tract: a preliminary clinical trial 

T. Tanaka, M. Takahashi, N. Nitta, S. Ota, A. Sonoda, M. Yamasaki, A. Furukawa, K. Murata, Y. Saito; Otsu/JP 

P3 Percutaneous gastrostomy: long-term experience 

S. Zaid, A. Curti, P. Stradiotti, A. Annoni, F. Perona, G. Cornalba; Milan/IT 

P4 Microcatheter-port system with the use of a coaxial method for hepatic intraarterial chemotherapy 

N. Toyota, H. Kakizawa, M. Hieda, N. Hirai, T. Tachikake, N. Matsuura, K. Ito; Hiroshima/JP 

P5 Endovascular treatment of chronic splanchnic syndrome 

E. F. Dannenberg, A. B. Huisman, D. G. Gerrits, R. P. Veenstra, J. J. Kolkman, R. H. Geelkerken; Enschede/NL 

P6 Co-morbidities prolong pancreatic drainage duration of catheterization 

H.B. D'Agostino, M. Rodrigo, V.E. Prieto Ventura, R. Vea, G. Sangster, A. Carbo; Shreveport/US 

P7 Percutaneous radiologic gastrostomy and gastrojejunostomy in children 

D. Akinci, T. Ciftci, D. Kaya, M. Ozmen, O. Akhan; Ankara/TR 

P8 A review of 125 computed tomography-guided percutaneous treatments of residual cavities after hydatidectomy 

I.I. Ikramov, N.M. Djuraeva, M.F. Maksudov; Tashkent/UZ 

P9 Percutaneous radiological gastrostomy in advanced amyotrophic lateral sclerosis 

D. Righi, M.A. Ruffino, A. Doriguzzi Breatta, A. Genovesio, A. Calvo, G. Gandini; Turin/IT 

P11 Endovascular repair of hypogastric artery aneurysms: nine-year experience 

R.A. Lookstein, S. Nowakowski, P.A. Stangl, A. Carroccio, S.H. Ellozy, T. Jacobs, V. Teodorescu, J.L. Weintraub, 

M.L. Marin; New York/US 

P12 Withdrawn by authors 

P13 Preclose technique for percutaneous repair of large-bore femoral access in percutaneous aortic stent-graft intervention 

D.Y. Lee, J.H. Yoon, S.H. Kim, K.-H. Lee, J.Y. Won; Seoul/KR 

P14 Endovascular repair of inflammatory aortic aneurysms: long-term results 

S.B. Puchner, R.A. Bucek, C. Loewe, T. Hoelzenbein, G. Kretschmer, J. Lammer; Vienna/AT 

P15 Endovascular abdominal aortic aneurysm repair and renal dysfunction: comparison between suprarenal and 

infrarenal endograft fixation 

R. Iezzi, A.R. Cotroneo, A. Pierro, D. Giancristofaro, V. Pasqua, D. Pascali, M.L. Storto; Chieti/IT 

P16 Endovascular stenting of thoracic aortic pathologies 

R. Jindal, M.P. Jenkins, R. Gibbs, J.H. Cowie, M. Clark, N.J. Cheshire, M. Hamady; London/UK 

P17 Endovascular treatment of abdominal aortic aneurysms. Technical success does not mean overall success in treating 

abdominal aneurysms 

M. Pomoni, D. Maras, G. Sfyroeras, K. Papadopoulos, K. Bacogianis, D. Tzavoulis, E. Gambroula, N. Batakis; Athens/GR 

P18 A single-centre experience in the treatment of ruptured abdominal aneurysms using endovascular stent grafts 

W.C. Loan, C. Voon Soong, C. Boyd, R. Hannon, L. Johnston, L. Lau, B. Lee; Belfast/UK 

P19 Hypogastric artery embolization during endovascular treatment of abdominal aortic aneurysms 

M. Corona, P. Nardis, F. Fanelli, V. Dominelli, A. Conchiglia, E. Boatta, R. Passariello; Rome/IT 

P20 The role of the left subclavian artery in patients with short proximal neck during stent-graft treatment of thoracic 

aortic pathologies 

F. Fanelli, M. Corona, P. Nardis, A. Conchiglia, E. Boatta, P. Rossi, R. Passariello; Rome/IT 


Rome 2006 


P21 Flat-panel computed tomography as a new perinterventional imaging modality in aortic stentgraft procedures. 

A work in progress 

E. Rabitsch, H. Illiasch, W. Eicher, W. Wandschneider, K.A. Hausegger; Klagenfurt/AT 

P22 Dissections of the thoracic aorta with concomitant aneurismal disease -possibilities for endovascular therapy 

O. Rowinski, Z. Galazka, M. Januszewicz, M. Wojtaszek, K. Milczarek, J. Szmidt; Warsaw/PL 

P23 Percutaneous lumbar interbody fusion: application of translaminar facet screws under computed tomographyguidance 

N. Amoretti, E. Hovorka, M.-E. Fonquerne, M. Rouquette, P. Boileau, J.-N. Bruneton; Nice/FR 

P24 Percutaneous discectomy. Clinical experience and results 

A.D. Kelekis1, D. Filippiadis1, A.L. Kelekis2, A. Nikita1, C. Vergadis1, E.N. Brountzos1, A. Gouliamos1; 1Athens/GR, 

2Thessaloniki/GR 

P25 Pain treatment in vertebral fractures by percutaneous vertebroplasty. Our experience and future perspectives 

G. Lingua, G. Gallarato, F. Testa, L. Fenoglio, F. Pedrazzini, M. Grosso; Cuneo/IT 

P26 Percutaneous computed tomography-guided radiofrequency ablation of osteoid osteoma with multi-tined expandable 

electrode 

L. Crocetti, R. Cioni, R. Lencioni, V. Zampa, S. Ortori, E. Bozzi, V. Consoli, C. Bartolozzi; Pisa/IT 

P27 Newly developed isocenter puncture method for percutaneous unipedicular vertebroplasty. A work in progress 

M. Yoshimatsu, K. Takizawa, Y. Nakajima, S. Sakaino, Y. Ogawa, M. Funakubo, K. Yagihashi; Kawasaki/JP 

P28 Heat distribution in the spinal canal during radiofrequency ablation of vertebral bodies. An experimental study 

A. Adachi, T. Kaminou, M. Hashimoto, K. Sugiura, Y. Takaki, T. Kawai, T. Ihaya, T. Ogawa; Yonago/JP 

P29 CT-guided injections of oxygen-ozone for the treatment of lumbar disc herniations: indications and technical 

approach. 

N. Limbucci, F. Salvati, V. Zecca, L. Mancini, M. Gallucci, C. Masciocchi; L'Aquila/IT 

P30 Foraminal corticosteroid injections in cervical neuralgias under computed tomography guidance (220 patients) 

R. Loffroy, B. Guiu, J. Mazaud, D. Ben Salem, J.P. Cercueil, D. Krause; Dijon/FR 

P31 Interest of the cortico-steroids epidural injection in the case of massive intracanalar lumbar disk herniations (12 

patients) 

R. Loffroy, D. Ben Salem, B. Guiu, J. Mazaud, M. Dranssart, J.P. Cercueil, D. Krause; Dijon/FR 

P32 Radiofrequency ablation of osteoid-osteoma: initial results with a bipolar ablation device 

J.E. Wildberger1, J. Tacke2, R.W. Günther1, A.H. Mahnken1; 1Aachen/DE, 2Passau/DE 

P33 Use of ultrasound for image guidance for temperomandibular joint (TMJ) injections in pediatric patients with 

arthritis 

B.L. Connolly, M. Chan, M. Temple, P. Chait, P. John, J. Amaral; Toronto, ON/CA 

P34 Treatment of malignant bone metastases by magnetic resonance guided ultrasound surgery 

A.N. Beck, S. Hengst, J. Ricke; Berlin/DE 

P35 Bilateral carotid angioplasty and stenting 

M. Henry1, I. Henry2, G. Lakshmi3, R. Sriram3, P.C. Rath4; 1Nancy/FR, 2Bois-Bernard/FR, 3Chennai/IN, 4Hyderabad/IN 

P36 Carotid angioplasty and stenting: selection of the appropriate stent 

M. Henry1, I. Henry2, A. Polydorou3, A. Polydorou3, M. Hugel1; 1Nancy/FR, 2Bois-Bernard/FR, 3Athens/GR 

P37 Carotid stenting without cerebral protection: results in 400 patients 

F. Perona, G. Dalla Pietà, L. Valvassori, E. Boccardi, G. Cornalba; Milan/IT 

P38 New distal embolic protection device using the FiberNetTM, a three-dimensional filter. First carotid and renal human 

study 

M. Henry1, A. Polydorou2, N. Liasis2, I. Henry3, M. Hugel1; 1Nancy/FR, 2Athens/GR, 3Bois-Bernard/FR 

P39 Carotid arterial stenting without neuroprotection: experience in 92 patients with 105 consecutive lesions 

M. Rengel, A. Laborada, C. Tejero, J. Medrano, A. Mainar, T. Higuera, M.A. De Gregorio; Zaragoza/ES 

P40 “Real world” TAXUS® Liberté outcomes: six-month results from Phase I of the TAXUS OLYMPIA post-approval registry 

W.H. Ahmed 1, R. Zambahari 2, I. Al-Rashdan 3, A. Al Naeemi 4, F.A. Saeed 5; 1Jeddah/SA, 2Kuala Lumpur/MY, 

3Kuwait City/KW, 4Abu Dhabi/AE, 5Manama/BH 

61



P41 Automated computed tomography-angiography quantification of internal carotid artery stenosis: a pilot trial 


P42 Computed tomography-angiography quantification of internal carotid artery stenosis: assessment of inter-observer 

variability using luminal area versus luminal diameter measurements 


P43 Evaluation by magnetic resonance imaging of the effectiveness of cerebral protection during carotid artery stenting 

K. Zelenak, E. Kurca, J. Zelenakova, V. Nosal; Martin/SK 

P44 Use of angio-volumetric computed tomography in the pre-planning of internal carotid artery stenting 

M. Stefanini, A. Spinelli, L. Maresca, S. Fabiano, D. Konda, M. Messina, R. Gandini, G. Simonetti; Rome/IT 

P45 Sixty four-row multidetector computed tomography of carotid arteries: low-dose iodinated contrast material protocol 

F. Cesarani, S. Cacherano, V. Varni, M. Macagno, M. Garruso; Asti/IT 

P46 Carotid artery stenting in elderly people 

C. Setacci1, G. de Donato1, A. Cremonesi2, F. Castriota2, E. Chisci1, A. Cappelli1, M. Pieraccini1; 1Siena/IT, 2Cotignola/IT 

P47 Patients with chronic renal failure undergoing carotid artery stenting: use of gadolinium-diethylenetriaminepentacetic 

acid, electroencephalographic monitoring, and post-intervention cerebral nuclear magnetic resonance 

M. Messina, S. Fabiano, A. Spinelli, M. Stefanini, R. Gandini, G. Simonetti; Rome/IT 

P48 Non-embolic neurologic complications in carotid revascularization: surgical and endovascular comparison 

I. Oran1, H. Posac?oglu1, G. Demirpolat2, M. Parildar1, A. Memis1; 1Izmir/TR, 2Kahramanmaras/TR 

P49 Carotid artery stenting: a single center six-year experience 

F. Fanelli, F.M. Salvatori, M. Corona, G. Luppi, E. Boatta, A. Conchiglia, R. Passariello; Rome/IT 

P50 Management of atheromatous disease of the extracranial carotid artery with wallstent application alone: A preliminary 

experience 

B. Üstünsöz, S. Ugurel, U. Bozlar, M. Koroglu, I. Somuncu; Etlik-Ankara/TR 

P51 Diagnostic accuracy of magnetic resonance imaging in arrhythmogenic right ventricular cardiomyopathy 

R.E. Maksimovic 1, T. Dill 2, A. Ristic 1, M. Dunjic 1, D.S. Simeunovic 1, P.M. Seferovic 1; 1Belgrade/YU, 2Bad Nauheim/DE 

P52 Aortic calcification on computed tomography as a predictor of coronary artery obstructive disease 

J.H. Kim, C.H. Park, S.J. Choi, J.E. Kim, H.S. Kim; Incheon/KR 


P54 Retrospective analysis of coronary artery bypass graft imaging with 16- and 64-slice spiral computed tomography 

Z. Zhang, Z. Jin, Y. Wang, L. Kong, L. Zhang, L. Song; Beijing/CN 

P55 ECG-gated 64-detector row cardiac computed tomography: Imaging the heart valves 

V. Rachapalli, A.M. Veitch, N. Manghat, G. Morgan-Hughes, C. Roobottom; Plymouth/UK 

P56 Is coronary imaging with multislice computed tomography still impossible in patients with atrial fibrillation? 

Comparison of a new frequency adapted multislice computed tomography reconstruction algorithm and standard 

invasive angiography 

A. Kovács, T. Sommer, C. Probst, P. Nähle, M. Hackenbroch, H.H. Schild, S. Flacke; Bonn/DE 

P57 Usefulness of electrocardiography-gated multidetector computed tomography in the management of patent ductus 

arteriosus in adult cases 

K. Takase, H. Ota, H. Saito, A. Ichinose, S. Takahashi; Sendai, Miyagi/JP 

P58 Noninvasive evaluation of cardiac veins with 64-multislice computed tomography-angiography in the planning of 

pacing and electrophysiology 

D. Lumia, G. Carrafiello, A. Giorgianni, M. Mangini, C. Recaldini, C. Fugazzola; Varese/IT 

P59 Real-time computed tomography-guided fluoroscopy-guided intraventricular navigation: a readily available technique 

D.A. Nussbaum1, P. Gailloud2, K. Murphy2; 1Philadelphia/US, 2Baltimore/US 

P60 Endovascular treatment of ruptured intracranial aneurysms in 65 patients using Guglielmi detachable coils 

H.E. Westerlaan, D. Fiore, J. Gravendeel, L.A. Rodiger, R.J. Groen, J.A. Mooij, M. Oudkerk; Groningen/NL

Rome 2006 


P61 Mechanical thrombectomy and thrombolysis in patients with severe cerebral sinus thrombosis 

K.P. van Lienden, J. Stam, C.B. Majoie, O.M. van Delden, J.A. Reekers; Amsterdam/NL 

P62 Clinical interests of in-space three-dimensional angiography 

D. Ilic, S. Ristic, P. Bosnjakovic; Nis/YU 

P63 Upgrading predictivity before interventional procedures: modern tools 

M. Legeais, J.P. Cottier, D. Herbreteau; Tours/FR 

P64 Computer assisted simulation of ultrasound guided procedures. 

R.A. Ratnalingam, D. Coates, J. Leong, D.O. Kessel, D. Magee, Y. Zhu; Leeds/UK 

P65 Basic investigation on cisplatin-eluting gelatin microspheres 

N. Nitta1, S. Ohta1, A. Sonoda1, T. Tanaka1, A. Furukawa1, M. Takahashi1, K. Murata1, T. Sakamoto2, Y. Kimura3, Y. Tabata3; 1Otsu/JP, 2Konan/JP, 3Kyoto/JP 

P66 Protective embolization of utero-ovarian anastomoses during uterine fibroids embolization 

J. Maskova, M. Mara; Prague/CZ 

P67 Percutaneous vascular embolization using nitinol vascular plugs 

B.E. Cil1, B. Peynircioglu1, M. Canyigit1, K. Lagios2, F. Balkanci1; 1Ankara/TR, 2Athens/GR 

P68 Comparison of computed tomography-angiography and digital subtraction-angiography for displaying vascular 

anatomy relevant to regional therapy for liver cancers 

S.C. Rose, G. Iussich, G. Casola; San Diego/US 

P69 Product optimization and characterization of Ibuprofen drug-eluting beads for uterine artery embolization 

R. Taylor 1, V. Gonzalez 1, Y. Tang 1, R. Palmer 1, S. Small 1, A. Laurent 2, M. Wassef 2, J. Namur 2, J.P. Pelage 2, A. Lewis 1; 

1Farnham/UK, 2Paris/FR 

P70 Initial clinical experience using the Amplatzer vascular plug 

D.J. Tuite, J.V. Patel, A.A. Nicholson, D.R. Shaw, S. McPherson, D.O. Kessel; Leeds/UK 

P71 Embolization in the treatment of epistaxis 

A. Szyma?ska, M. Szajner, W. Krzyzanowski, P. Trojanowski, M. Szczerbo-Trojanowska; Lublin/PL 

P72 Management of renal angiomyolipomas by selective arterial embolization 

M. Echenagusia Boyra, G.I. Rodríguez Rosales, A. Lancharro Zapata, J. Crespo San Jose, G. Simo Muerza, 

F. Camuñez Alonso; Madrid/ES 

P73 Partial embolisation of the thyroid gland in hyperthyroidism 

K. Brzozowski, P. ?ukowski, G. Kami?ski, A. Jaroszuk, P. Twarkowski; Warsaw/PL 

P74 Endovascular management of para pancreatic aneurysms 

A. Sato, T. Yamada, K. Takase, T. Matsuhashi, T. Ishibashi, S. Takahashi; Sendai/JP 

P75 Embolization of symptomatic non-functioning renal allograft in pediatric patients 

A. Belenky1 , G. Bartal2, E. Mor2, N. Bar-Natan2, E. Atar1; 1Petach Tiqwa/IL, 2Kfar-Saba/IL 

P76 The use of hemoglobin concentration in establishing ongoing hemorrhage after transcatheter splenic artery 

embolization for traumatic splenic injury 

J.A. Jednacz, R.E. Lambiase; Providence/US 

P77 Can failure of transcatheter splenic artery embolization for traumatic splenic injury be predicted? 

J.A. Jednacz, S. Ahn, R.E. Lambiase; Providence/US 

P78 Utility of segmental Lipiodol-transarterial embolization for hepatocellular carcinoma with various tumor stages and 

hepatic functional reserves, especially assessed by the Japan Integrated Staging Score system 

H. Sakaguchi1, H. Anai1, T. Tanaka1, K. Yamamoto1, K. Morimoto1, K. Kichikawa1, H. Uchida2; 1Nara/JP, 2Ichinomiya/JP 

P79 Percutaneous management of iatrogenic arterial pseudoaneurysms associated with orthopaedic and abdominal 

surgery 

J.R. Fortuño, J. Perendreu, J. Falco, J. Branera, P. Bermudez; Sabadell/ES 

P80 Endovascular coil embolization under flow regulation using an occlusion balloon catheter 

N. Nishida, K. Nakamura, T. Kitayama, M. Tokunaga, Y. Sakai, M. Hamuro, Y. Inoue; Osaka/JP 


63



P81 Outcomes of uterine artery embolization using gelatin sponge particles for symptomatic fibroids 

G.I. Rodríguez Rosales, C. Nicolás Martín, N. Jiménez Gómez, B. Calonge Arabaolaza, M. Gómez Rufete, 

N. Alonso Valentín, I.T. Pinto Pabón; Madrid/ES 

P82 Efficacy of transarterial embolization using N-butyl-2-cyanoacrylate and Lipiodol for acute arterial bleeding in 

patients with coagulopathy 

M. Funakubo, K. Takizawa, Y. Nakajima, M. Yashimatsu, Y. Ogawa, K. Yagihashi, J. Matsumoto, H. Niimi; Kawasaki/JP 

P83 Techniques of coronary fistulae embolization 

P. Waldenberger, O. Pachinger; Innsbruck/AT 

P84 Catheter-directed gastric artery fundal ablation modulates systemic ghrelin levels in a swine model 

A. Arepally, B.P. Barnett, E. Montgomery, T. Patel; Baltimore/US 

P85 Transarterial chemoembolization in the treatment of hepatocellular carcinoma: a single-center experience over a 

five-year period 

S. Herber, G. Otto, J. Schneider, C. Düber, M.B. Pitton; Mainz/DE 

P86 Blunt splenic injury: efficacy of superselective transcatheter arterial embolization 

C.-P. Chou, Y.H. Kim, R. Levenson, D. Kim, P. Surapaneni, K. Kandarpa; Worcester/US 

P87 Use of the Amplatzer Vascular Plug for arterial and venous embolization: Preliminary experience 

K.D. Hagspiel1, J.F. Angle1, A.H. Matsumoto1, D.A. Leung2, M.D. Dake1, N.L. Harthun1, U.C. Turba1; 1Charlottesville/US, 

2Richmond/US 

P88 Value of Hepatic angiography and Brehmstrallung imaging in hepatic radioembolisation 

A.J. Sebastian, T. Szysko, A. Al-Nahhas, N.P. Tait; London/UK 

P89 Creation of an animal model of post-hepatic portal hypertension by inducing hepatic vein stenosis in swine 

H. Ferral1, G. Behrens1, V. Crisostomo2, M.J. Alonzo1, N.H. Patel1, M. Maynar2; 1Chicago/US, 2Caceres/ES 

P90 Experimental investigation on photodynamic effect of polyethylene glycol-modified fullerene 

N. Nitta1, S. Ohta1, A. Sonoda1, T. Tanaka1, M. Takahashi1, K. Murata1, T. Sakamoto2, Y. Tabata3, J. Liu3, M. Yamada3; 1Otsu/JP, 2Konan/JP, 3Kyoto/JP 

P91 Effect of inflammation on angiogenesis in restenosis 

M.A. Cura, E.A. Sprague; San Antonio/US 

P92 A new foreign body retrieval device with an adjustable snare: experimental evaluation in a swine model 

A. Konya; Houston/US 

P93 Ethiodized oil-based capillary embolization techniques used for transcatheter renal ablation in rabbit kidneys inoculated 

with VX2 carcinoma: a pilot study 

A. Konya, L. Stephens, K.C. Wright; Houston/US 

P94 Active connection matrix system: a new paradigm for intelligent image processing in digital subtraction angiography 

M. Midulla1, P.M. Buscema2, E. Grossi1, G. Castellazzi1, F. Perona1, G. Cornalba1; 1Milan/IT, 2Rome/IT 

P96 Closed renal circuit for ethanol embolization: preliminary experiment in a pig model 

S. Onozawa, S. Murata, H. Tajima, F. Hidaka; Tokyo/JP 

P97 Determination of effective doses and skin doses during computed tomography interventional procedures 

I. Tsalafoutas, V. Tsapaki, P. Maniatis, C. Triantopoulou, A. Gorantonaki, J. Siafas, J. Papailiou; Athens/GR 

P98 A new design for a self-expanding, nitinol, microporous, covered stent. An experimental study 

T. Ishibashi1, A. Sato1, T. Matsuhashi1, T. Yamada1, K. Takase1, S. Sato1, Y. Nakayama2; 1Sendai/JP, 2Osaka/JP 

P99 Type II endoleak model and aneurysm sac embolization: an experimental study 

M. Nango, Y. Sakai, M. Hamuro, K. Nakamura, R. Yamada, Y. Inoue; Osaka/JP 

P100 Complex stent assemblies: feasibility of stent-through-stent deployment 

S.A. Sobolevsky, D. Rabkin, B. Janne d'Othee, E. Lang; Boston/US 

P101 Integrative imaging-genomic analysis of hepatic cell carcinoma with biphasic computed tomography to predict 

treatment response profiles 

M.D. Kuo 1, J. Gollub 2, C. Sirlin 1, C. Ooi 3; 1San Diego/US, 2Stanford/US, 3Hong Kong/HK

Rome 2006 


P102 Rhenium-188-mercaptoacetyltriglycine-filled balloon dilation following bare-stent placement results in reduced tissue 

hyperplasia in a rabbit esophageal model 

J.H. Shin, H.-Y. Song, S.K. Lee, T.-H. Kim, E.-Y. Kim, C.-W. Woo; Seoul/KR 

P103 The analysis of hydrophilic wires for debris and rapidity of drying using high-power optical microscopy 

C.K. Cook; Weston Super Mare/UK 

P104 Selective induction of mild brain hypothermia using retrograde venous perfusion with a catheter-based technique: 

a feasibility pilot study in two animal models 

Y. Hoogeveen, A. Hoedemaekers, P. Weerwind, L. Schultze Kool; Nijmegen/NL 

P105 Renal, mesenteric, and iliac arteries ablation in a rabbit model using radiofrequency guidewires: comparison 

between conventional angiography and pathologic findings 

N.K. Chang 1, Y.L. Shen 2, H.S. Yang 1, J.K. Kim 1; 1Gwang-ju/KR, 2Yan Bian/CN 

P106 Transauricular endovascular access through the ear artery or vein in rabbits: A novel platform for experimental 

endovenous or intra-arterial cardiovascular interventions 

D. Karnabatidis, K. Katsanos, A. Diamantopoulos, D. Siablis; Patras/GR 

P107 In-vivo imaging and quantitative analysis of angiogenesis in animal models with the application of sophisticated 

image processing and analysis algorithms 

K. Katsanos1, D. Karnabatidis1, A. Diamantopoulos1, G.C. Kagadis1, A. Daskalakis1, D. Cavouras2, G.C. Nikiforidis1, D. Siablis1; 1Patras/GR, 2Athens/GR 

P108 A passive guidewire for magnetic resonance-guided vascular interventions in humans 

A.L. Jacob, R. Mekle, R. Huegli, G.M. Bongartz, K. Scheffler, D. Bilecen; Basle/CH 

P109 The reduction of in-stent restenosis of ultra-low and low profile poly[bis(trifluoroethoxy)phosphazene]-CeloNova 

nanocoating of bare cobalt chromium versus Taxus Express and Cypher stents in a porcine model 

B.A. Radeleff, R. Lopez-Benitez, U. Stampfl, S. Stampfl, C. Sommer, H. Thierjung, I. Berger, G.W. Kauffmann, 

G.M. Richter; Heidelberg/DE 

P110 Effects of stent-based radiation therapy after carotid artery stenting 

J.M. Schmehl1, P. Muschick2, U. Brehme1, C.D. Claussen1, S.H. Duda2, G. Tepe1; 1Tübingen/DE, 2Berlin/DE 

P111 Elution kinetics in a in-vitro model of paclitaxel drug-eluting stents. Evaluation of three different polymers: drug 

ratio concentration 

R. Lopez-Benitez, B.A. Radeleff, U. Stampfl, S. Stampfl, G.W. Kauffmann, G.M. Richter; Heidelberg/DE 

P112 Non-fibroid indications for uterine artery embolization: 12 cases 

S.A. Kapranov, M.A. Kurtser, B.Y. Bobrov, A.A. Alieva, V.F. Kuznetsova, A.G. Zlatovratsky; Moscow/RU 

P113 Prophylactic embolization of placental disorders 

D. Henroteaux, L. Collignon, J.-L. Lismonde, M. Dubois, J.-M. Foidart; Liège/BE 

P114 Acute ischemic changes of uterine fibroids immediately after uterine artery embolization: evaluation by diffusionweighted 

magnetic resonance imaging 

S. Fuwa, Y. Matsuo, Y. Numaguchi, Y. Saida, N. Kobayashi; Tokyo/JP 

P115 Uterine artery embolization for fibroids. Is a hormone-free period of two months enough to achieve good results? 

J.M. Pisco, M. Duarte, A. Guerra, M.M. Monteiro, D.D. Santos, J. Castaño, F.M. Pires; Lisbon/PT 

P116 Endovascular treatment of varicocele. Our six-year experience in 918 patients 

F. Melchiorre, G. Lingua, F. Testa, F. Groppo Marchisio, F. Pedrazzini, M. Grosso; Cuneo/IT 

P117 Superselective angio-CT for female pelvis 

Y. Iwasaki, T. Kawauchi, M. Yamamoto, T. Kaji, S. Kosuda; Tokorozawa/JP 

P118 The role of radiological intervention in the management of complications of horseshoe kidneys. 

J. O'Brien, T. Persaud, O. Doody, E. Ward, O. Buckley, W. Torregiani; Dublin/IE 

P119 Medium- and long-term quality of life assessment in patients undergoing uterus fibroid embolization 

R.A. Bucek, S.B. Puchner, J. Lammer; Vienna/AT 

P120 Superselective transcatheter embolization of high-flow priapism 

F. Numan, M. Canta?demir, M. Özbayrak, H. Özer; ?stanbul/TR 


65



P121 Rhenium-188-mercaptoacetyltriglycine-filled balloon dilation in the treatment of recurrent urethral strictures: initial 

experience with five patients 

J.H. Shin, H.-Y. Song, T.-H. Kim, G.-Y. Ko, H.-K. Yoon, K.-B. Sung; Seoul/KR 

P122 Preoperative embolization of large uterine fibroids in 25 young women 

R. Loffroy, B. Guiu, M. Dranssart, J. Mazaud, D. Ben Salem, J.P. Cercueil, D. Krause; Dijon/FR 

P123 Treatment of hepatic and renal cysts by aspiration and Minocyclin hydrochloride injection 

M. Messina, E. Pampana, M. Chiocchi, L. Maresca, R. Gandini, G. Simonetti; Rome/IT 

P124 Nephrostomies: When its complicated. 

L. Ratnam, J. Raja, G. Munneke, U. Patel; London/UK 

P125 Preventive embolisation of renal angiomyolipomas 

O. Cosín, O. El Aassar, V. Chabbert, P. Otal, H. Rousseau, F. Joffre; Toulouse/FR 

P126 Therapeutic transcatheter arterial embolization in the management of intractable bladder haemorrahage from 

malignant pelvic tumors and bladder irradiation therapy 

J. Branera, J. Perendreu, J.R. Fortuño, J. Falco, A. Martin, P. Bermudez; Sabadell/ES 

P127 Long-Term results of percutaneous therapy of ureteric complications after renal transplantation 

C. Aytekin, F. Boyvat, U. Ozyer, T. Colak, M. Haberal; Ankara/TR 

P128 Evaluation of drug perfusion during balloon occluded arterial infusion for gynecologic tumors using angio-MRI system. 

R. Nagashima, J. Koizumi, S. Takurou, T. Hashimoto, K. Myohjin, S. Kawada, M. Saitoh, M. Naganuma, T. Yamashita, 

Y. Imai; Kanagawa/JP 

P129 New dialysis access graft with self-sealing ports 

R. Uflacker; Charleston/US 

P130 Results of a peripheral cutting balloon TM prospective multicenter European registry in hemodialysis vascular access 

J.H. Peregrin, M. Ro?ek; Prague/CZ 

P131 Pharmacomechanical thrombectomy of thrombosed hemodialysis grafts and native fistulas using the Castañedabrush 

catheter: preliminary results 

S. Heye, F. Van Kerkhove, K. Claes, G.A. Maleux; Leuven/BE 

P132 Percutaneous transluminal angioplasty of hemodialysis-related inflow arterial stenosis: results of patency rates in 32 

patients 

S. Kariya 1, N. Tanigawa 2, H. Kojima 1, A. Komemushi 1, Y. Shomura 1, Y. Ueno 1, T. Shiraishi 3, T. Kawanaka 3, S. Sawada 1; 

1Hirakata Osaka/JP, 2Hirakata/JP, 3Higashiosaka Osaka/JP 

P133 Percutaneous transluminal angioplasty for hemodialysis-related central venous stenosis: results of patency rates 

S. Kariya 1, N. Tanigawa 2, H. Kojima 1, A. Komemushi 1, Y. Shomura 1, Y. Ueno 1, T. Shiraishi 3, T. Kawanaka 3, S. Sawada 1; 

1Hirakata Osaka/JP, 2Hirakata/JP, 3Higashiosaka Osaka/JP 

P134 Outcomes of tunnelled internal jugular catheters in 425 patients. A single-center experience 

B. Peynircioglu, F. Ozkan, M. Canyigit, S. Geyik, T. Hazirolan, B.E. Cil; Ankara/TR 

P135 Treatment and follow up of arterial-venous fistula (FAV) in hemodialysis patient: Role of interventional radiology 

E. Paci, M. Verdecchia, S. Alborino, L. Carbonari, R. Candelari, E. Antico; Ancona/IT 

P136 Guidewire "pull-through technique" in native forearm blood access malfunctions 

Y. Watanabe, K. Matsuura, A. Takada, K. Tanno, N. Tashima, I. Uejima, O. Tanaka; Saitama/JP 

P137 Angiojet mechanical thrombectomy for percutaneous recanalization of thrombosed hemodialysis grafts: long-term 

results 

D. Karnabatidis, D. Siablis, K. Katsanos, A. Diamantopoulos, N. Christeas; Patras/GR 

P138 Plasmin: phase I clinical trial in hemodialysis graft occlusions 

A.H. Matsumoto; Charlottesville/US 

P139 Cutting-balloon angioplasty in hemodialysis patients for vascular stenoses resistant to high-pressure conventional 

balloon-angioplasty 

L. Oguzkurt1, F. Tercan1, U. Özkan1, T.Z. Nursal1, Z. Koc1, F. Boyvat2; 1Adana/TR, 2Ankara/TR

Rome 2006 


P140 Haemodialysis lines: should we strip? 

A.G. Davies, S. Kamath, H.L. Fuller, C. Bingham, A.F. Watkinson, D.C. Kinsella; Exeter/UK 

P141 Use of Viabahn endoprosthesis in dialysis access graft or fistula outflow stenoses or occlusions 

T.G. Van Ha, B. Funaki, J. Lorenz; Chicago/US 

P142 Clinical significance of fistulography by brachial artery approach in hemodialysis patients 

Y.D. Won1, K.T. Kim2, H.J. Chun2, Y.O. Kim2; 1seoul/KR, 2Seoul/KR 

P143 Salvaging and maintaining non-maturing Brescia-Cimino fistulas by percutaneous intervention 

Y.D. Won, H.H. Song, K.T. Kim, H.J. Chun; Seoul/KR 

P144 Sharp needle recanalization for salvaging AV accesses with chronically occluded outflow 

N. Goel, I. Schur, G.A. Miller, M.C. Jotwani, J. Licht, E. Koh; New York/US 

P145 Percutaneous transhepatic treatments for biliary complications following living donor liver transplantation 

G.-Y. Ko, K.-B. Sung, H.-K. Yoon; Seoul/KR 

P146 Retrievable, polytetrafluoroethylene-covered, self-expandable nitinol stent insertion in benign biliary strictures 

D. Gwon, G.J. Lee, J.C. Shim, M.H. Seo, H.K. Kim; Seoul/KR 

P147 Interventional management of choledocholithiasis 

E. Yamanouchi, R. Kumano, R. Teramoto, S. Hamaguchi, T. Hattori; Yokohama/JP 

P148 Percutaneous interventional therapy of persistant biliary fistulas 

B. Yagci1, M. Parildar2, I. Oran2, G. Demirpolat3, A. Memis2; 1Denizli/TR, 2Izmir/TR, 3Kahramanmaras/TR 

P149 Preoperative portal vein embolization with a mixture of gelatin-sponge particles and iodized oil: efficacy and safety 

H. Kakizawa1, N. Toyota1, A. Naito2, Y. Fujimura1, M. Hieda1, N. Hirai1, T. Tachikake1, N. Matsuura1, K. Ito1; 1Hiroshima/JP, 

2Kure/JP 

P150 Role of interventional radiology in the management of severe iatrogenic biliary tract complications 

G. Giordano, M. Midulla, M. Cariati, F. Perona, A. Sacrini, G. Cornalba; Milan/IT 

P151 Lithotripsy for choledocholithiasis via the percutaneous transhepatic gallbladder drainage route 

R. Kumano, E. Yamanouchi, R. Teramoto, S. Hamaguchi, T. Hattori; Yokohama/JP 

P152 A new nitinol stent for palliation of malignant biliary obstructions: preliminary results of a multicenter study 

J. Urbano1, S. Gil2, J. Blazquez1, J. Guijarro3, A. Echenagusia1, C. Castaño4, J. Falco4, A. Gª-Entrena5, M. Trillo6, E. Escalante4; 1Madrid/ES, 2Alicante/ES, 3Valencia/ES, 4Barcelona/ES, 5Granada/ES, 6Orense/ES 

P153 True one-step percutaneous transhepatic cholangiogram and stent: assessing Spongostan embolization of the 

percutaneous transhepatic tract 

R.A. England1, R.A. Lavis2, D.C. Kinsella2, A.F. Watkinson2; 1Carlisle/UK, 2Exeter/UK 

P154 Hepatobiliary intervention revisited 

C. Cronin, D. Lohan, C. Meehan, N. Gough, R. McLaughlin, G.J. O'Sullivan; Galway/IE 

P155 Transcatheter arterial chemoembolization with HepaSphereTM Microspheres mixed with a chemoterapy agent: preliminary 

experience of a multicentric study 

F. Melchiorre1, P. Petruzzi2, C. Massa Saluzzo3, P. Quaretti3, C. Vignali2, M. Grosso1; 1Cuneo/IT, 2Pisa/IT, 3Pavia/IT 

P156 Chemoembolization and radiofrequency ablation as a complementary treatment in hepatic hypervascular malignant 

tumors 

M. Pomoni, S. Mylona, L. Thanos, E. Stroumpouli, N. Fragiskou, D. Tzavoulis, E. Gambroula, N. Batakis; Athens/GR 

P157 Percutaneous treatment of biliary fistulas after ortothopic liver transplantation 

A. Doriguzzi Breatta, D. Righi, M.A. Ruffino, A. Calvo, R. Faletti, G. Gandini; Turin/IT 

P158 Role of interventional radiology in the treatment of biliary strictures following orthotopic liver transplantation 

D. Righi, A. Doriguzzi Breatta, M.A. Ruffino, A. Genovesio, R. Faletti, G. Gandini; Turin/IT 

P159 Expanded-polytetrafluoroethylene and fluorinated ethylene propylene-covered metallic stents versus uncovered 

mesh stents for palliation of malignant biliary disease. Clinical results in 160 patients 

M. Krokidis1, F. Fanelli2, A. Hatzidakis1, A. Conchiglia2, M. Bezzi2, N. Gourtsoyiannis1, R. Passariello2; 1Heraklion/GR, 

2Rome/IT 


67



P160 Radiologic-endoscopic combined treatment of biliary ducts transection: medium- and long-term follow-up results 

M. Corona, F.M. Salvatori, F. Fanelli, G. Luppi, E. Boatta, A. Conchiglia, R. Passariello; Rome/IT 

P161 Endovascular treatment of the portal vein thrombosis after pediatric liver transplantation 

F.C. Carnevale, A.T. Machado, A.M. Moreira, N.E. Gibelli, U. Tannuri, J.G. Maksoud; Sao Paulo/BR 

P162 Histopathologic changes of renal cell carcinoma after magnetic resonance-guided cryoablation 

T. Mogami, J. Harada, Y. Yamaguchi, K. Kishimoto; Chiba/JP 

P163 Establishing a renal radiofrequency ablation service: early experience in 15 cases 

S. Kamath, R. Pocock, M. Scott, M. Crundwell, A.F. Watkinson; Exeter/UK 

P164 Percutaneous radiofrequency ablation of lung tumour 

G. Giordano, M. Cariati, M. Midulla, A. Sacrini, S. Zaid, G. Cornalba; Milan/IT 

P165 Breast radiofrequency: study on non-surgical patients 

J. Palussière, C. Henriquès, F. Valentin, M. Asad-Syed, S. Mathoulin, M. Kind, M. Debled, M.-H. Dilhuydy, L. Mauriac; 

Bordeaux/FR 

P166 Cross-sectional imaging predictors of pulmonary shunting in patients with hepatocellular carcinoma considered for 

treatment with Yttrium-90 Theraspheres 

T.A. Shin1, J.R. Stone1, W. Swee1, S.H. Caldwell1, D.A. Leung2, T.A. Rich1, K.D. Hagspiel1; 1Charlottesville/US, 2Richmond/US 

P167 Radiofrequency ablation and percutaneous vertebroplasty: a combined therapy for metastatic spinal tumors 

T. Kaminou, A. Adachi, T. Kawai, M. Hashimoto, K. Sugiura, Y. Takaki, T. Ogawa, K. Ihaya; Yonago/JP 

P168 Complications after computed tomography-guided percutaneous radiofrequency ablation of primary and secondary 

hepatic tumors. A five-year experience 

R.-T. Hoffmann1, T.F. Jakobs1, C.G. Trumm1, A. Schrader1, T.K. Helmberger2, M.F. Reiser1; 1Munich/DE, 2Luebeck/DE 

P169 Changes in the respiratory function induced by radiofrequency ablation for pulmonary malignancies 

T. Matsuoka1, T. Okuma1, M. Toyoshima2, A. Yamamoto1, Y. Oyama1, K. Nakamura1; 1Osaka/JP, 2Kobe/JP 

P170 Stereotactic placement of multiple probes for ablation of liver lesions 

R. Bale, M. Haidu, P. Kovacs, C. Hinterleithner, M. Knoflach, W.R. Jaschke; Innsbruck/AT 

P171 Computed tomography-guided percutaneous cryoablation of lung malignancy using 17-G ultra-thin cryoneedle: 

early experience 

J.Y. Won, K.-H. Lee, D.Y. Lee, H.K. Ko; Seoul/KR 

P172 Percutaneous ultrasound-guided cryoablation of small renal tumours. First European results 

J. Solvig, Ø. Østraat, K.V. Pedersen; Aarhus/DK 

P173 Percutaneous radiofrequency ablation in 216 patients with hepatocellular carcinoma: a six-year experience 

S. Mylona, M.-S. Grammenou-Pomoni, E. Stroumpouli, M. Gravanis, L. Thanos, N. Batakis; Athens/GR 

P174 Five-year survival after radiofrequency ablation of colorectal liver metastases. Results comparable to the best surgical 

series 

D.T. Nielsen, S.M. Sørensen, F.V. Mortensen; Aarhus/DK 

P175 Hepatic vascular applications of DynaCT 

N. Bedi, M.J. Wallace, R. Murthy; Houston/US 

P176 Radiological insertion and management of peritoneovenous shunt 

M.J. Bratby1, F.F. Hussain2, A.J. Lopez2; 1London/UK, 2Guildford/UK 

P177 Hepatic artery occlusion as a complication of continuous hepatic arterial infusion: comparison between gastroduodenal 

artery coil method and direct hepatic artery method 

T. Hashimoto, J. Koizumi, K. Myohjin, S. Kawada, M. Saito, R. Nagashima, M. Naganuma, T. Yamashita, Y. Imai; Isehara/JP 

P178 Characterization of irinotecan drug-eluting beads and in-vitro:in-vivo correlation 

R. Taylor, V. Gonzalez, Y. Tang, A. Lewis; Farnham/UK 

P179 Use of yttrium-90 microspheres for the treatment of liver neoplasia: long-term follow-up 

R. Lewandowski, B. Atassi, C. Wong, V. Gates, R. Ryu, K. Sato, M.F. Mulcahy, R. Salem; Chicago/US 

P180 Computed tomography-guided percutaneous core biopsy of small pulmonary nodules: diagnostic accuracy and 

complication rate 

C. Wolf1, M. Freund1, J. Bodner1, M. Hackl2, A. Tzankov1, W.R. Jaschke1; 1Innsbruck/AT, 2Natters/AT

Rome 2006 


P181 Tumor assessment in patients undergoing local chemotherapy: first experience with angiographic computed 

tomography images acquired with an angiographic C-arm system 

F.K. Wacker, B. Meyer, K.-J.J. Wolf; Berlin/DE 


P183 Percutaneous transluminal angioplasty of the subclavian arteries 

M. Henry1, I. Henry2, A. Polydorou3, A. Polydorou3, M. Hugel1; 1Nancy/FR, 2Bois-Bernard/FR, 3Athens/GR 

P184 Percutaneous transluminal angioplasty and stenting of extracranial vertebral artery stenoses 

M. Henry1, A. Polydorou2, I. Henry3, A. Polydorou2, M. Hugel1; 1Nancy/FR, 2Athens/GR, 3Bois-Bernard/FR 

P185 Percutaneous transluminal angioplasty for the treatment of infrapopliteal critical limb ischemia: early outcomes following 

the use of Sirolimus-eluting stents 

M. Bosiers1, K. Deloose1, J. Verbist2, P. Peeters2; 1Dendermonde/BE, 2Bonheiden/BE 

P186 Endovascular repair of complex internal iliac aneurysms using customised tapered stent-grafts 

J.E. Haslam, J. Hardman, D. Fay, M. Horrocks; Bath/UK 

P187 Cutting-balloon percutaneous transluminal angioplasty: treatment of choice in femoro-popliteal artery lesions 

P. Venetucci, V. Iaccarino; Naples/IT 

P188 Superior vena cava obstruction with lung carcinoma: endovascular stenting versus radiation therapy 

Y.-M. Han, H.-S. Kwak, G.-Y. Jin, J.-S. Kim; Chonju/KR 

P189 Feasibility of a contralateral approach to femoro-popliteal occlusive lesions 

K. Akimoto1, T. Mihara1, T. Ito1, T. Nishimura2; 1Nantan/JP, 2Kyoto/JP 

P190 “Full metal jacket” for recanalization of complete occlusions of superficial femoral artery 

D. Laganà, G. Carrafiello, M. Mangini, C. Recaldini, A. Giorgianni, C. Fugazzola; Varese/IT 

P191 Infra-popliteal revascularization in critical limb ischemia: three-year experience in endovascular and surgical treatment 

R. Rizzati, S. Tartari, M. Tilli, C. Aliberti, G. Benea; Ferrara/IT 

P192 Early experience with the Amplatzer® vascular plug in peripheral arteries 

O. Pellerin, L. Novelli, A.C. Raynaud, B. Louail, M. Sapoval; Paris/FR 

P193 Cutting-balloon angioplasty in the treatment of iliac artery in-stent restenosis 

D. Tsetis1, A. Katsamouris1, I. Kapralos1, T. Kostas1, A. Basile2, E. Manousaki1, N. Gourtsoyiannis1; 1Heraklion/GR, 

2Catania/IT 

P194 A trans-femoral and trans-tibial combined approach in the treatment of obstructions extending on popliteal and 

distal vessels origin 

L. Maresca, R. Gandini, M. Chiocchi, V. Pipitone, M. Stefanini, G. Simonetti; Rome/IT 

P195 Percutaneous transluminal angioplasty of infrapopliteal arteries. Limb salvage rate according to indications and 

arterial patency after treatment 

B. Koznar, J.H. Peregrin; Prague/CZ 

P196 Infrapopliteal paclitaxel-eluting stents for critical limb ischemia: six-month clinical and angiographic results 

D. Siablis, D. Karnabatidis, K. Katsanos, A. Diamantopoulos, P. Kraniotis, J. Tsolakis; Patras/GR 

P197 The role of Protégé self-expanding nitinol stent in the treatment of superficial femoral artery lesions: a work-inprogress 

F. Fanelli, M. Corona, P. Nardis, V. Dominelli, E. Boatta, A. Conchiglia, R. Passariello; Rome/IT 

P198 Infrapopliteal sirolimus-eluting stents for critical limb ischemia: one-year clinical and angiographic results 

D. Siablis, D. Karnabatidis, P. Kraniotis, K. Katsanos, A. Diamantopoulos, J. Tsolakis; Patras/GR 

P199 Frequency of stent fractures in the femoropopliteal artery 

M. Brodmann, H. Fröhlich, G. Seinost, A. Dorr, E. Pilger; Graz/AT 

P200 Renal angioplasty and stenting under protection. The way for the future? 

M. Henry1, I. Henry2, A. Polydorou3, A. Polydorou3, E. Le Borgne4, M. Hugel1; 1Nancy/FR, 2Bois-Bernard/FR, 3Athens/GR, 

4La Rochelle/FR 


69


P201 Polarized light: evidence of cholesterol embolism at renal stenting 

J. Urbano, F. Manzarbeitia, C. Caramelo; Madrid/ES 

P202 Long-term follow-up of patients with angioplasty of transplanted kidney artery 

J.H. Peregrin, J. St?íbrná, J. Lácha; Prague/CZ 

P203 Renal artery stenting in children 

C.A. McLaren, D.J. Roebuck; London/UK 


P204 Percutaneous interventions in the treatment of transplanted renal artery stenosis affecting graft perfusion. 

M. Wojtaszek, P. Kulisiewicz, M. Januszewicz, O. Rowinski, J. Szmidt, M. Durlik; Warsaw/PL 

P205 Endovascular management of Budd-Chiari syndrome 

M.A. Cura; San Antonio/US 

P206 Parallel technique for transjugular intrahepatic portosystemic shunt reduction: initial results 

S. Heye, F. Nevens, C. Verslype, G.A. Maleux; Leuven/BE 

P207 Short-term complications on liver and renal functions of balloon-occluded retrograde transvenous obliteration: 

changes in laboratory data 

T. Kitayama, K. Nakamura, M. Tokunaga, T. Ninoi, N. Nishida, R. Yamada, Y. Inoue; Osaka/JP 

P208 Bleeding of ectopic varices in cirrhotic patients: usefulness of transjugular intrahepatic portosystemic shunt 

P. Perreault, V. Vidal, L. Bouchard, L. Joly, M. Lafortune, G. Pomier-Layrargues; Montreal, PQ/CA 

P209 Value of carbon dioxide-wedged hepatic venography to identify the portal vein: comparison with iodinated, direct 

portography and analysis of predictive factors influencing its level of opacification 

G.A. Maleux, F. Nevens, S. Heye, C. Verslype, G. Marchal; Leuven/BE 

P210 Comparison of transjugular intrahepatic portosystemic shunt and balloon-occluded retrograde transvenous obliteration 

for control of gastric variceal bleeding 

Y.-h. Kim; Taegu/KR 

P211 Foam sclerotherapy for gastroduodenal varices and splenorenal shunt s. Evaluation by interventional radiologycomputed 

tomography system 

J. Koizumi1, T. Hashimoto1, R. Nagashima1, K. Myohjin1, T. Yamashita1, M. Iino1, Y. Kawawa1, K. Akimoto2, M. Muto1, Y. Imai1; 1Isehara/JP, 2Funai-gun/JP 

P212 Portal vein embolization prior to liver resection 

M. Midulla, M. Cariati, A. Sacrini, S. Zaid, F. Perona, G. Cornalba; Milan/IT 

P213 Percutaneous transhepatic angioplasty and stenting on portal vein stenosis complicating liver transplantation: tenyear 

experience at Queen Mary Hospital, Hong Kong Special Administrative Region, China 

K.K. Wong, W.K. Tso, H. Tung, L. Leong; Hong Kong/HK 

P214 Portal vein stenting for the treatment of steno-occlusive disease following pediatric liver transplantation 

G.-Y. Ko, K.-B. Sung, H.-K. Yoon; Seoul/KR 

P215 Relationship between hemodynamics of gastric varices and aggravation of esophageal varices after balloonoccluded 

retrograde transvenous obliteration 

H. Tanihata, M. Nakai, T. Iwamoto, H. Minamiguchi, N. Kawai, M. Kimura, K. Kishi, M. Sato; Wakayama/JP 

P216 Preoperative percutaneous transhepatic portal vein embolization with ipsilateral approach 

A. Sawada, T. Shimizu, Y. Sakuhara, D. Abo, K. Miyasaka; Sapporo/JP 

P217 Transcatheter sclerotherapy for gastric varices: relationship between portal pressure and worsening of esophageal 

varices 

M. Tokunaga, K. Nakamura, T. Kitayama, T. Ninoi, N. Nishida, R. Yamada, Y. Inoue; Osaka/JP 

P218 Clinical results of balloon-occluded retrograde transvenous obliteration of gastric and duodenal varices 

T. Minami1, S. Miyayama2, K. Taki2, Y. Ryu2, D. Inoue2, K. Nakamura2, O. Matsui1; 1Nanao/JP, 2Fukui/JP 

P219 Long-term results of transcatheter sclerotherapy for the treatment of gastric varices 

T. Ninoi1, K. Nakamura1, T. Kitayama1, M. Tokunaga1, N. Nishida1, R. Yamada1, T. Kaminou2, Y. Inoue1; 1Osaka/JP, 

2Yonago/JP 

P220 Six-year experience with transjugular intrahepatic portosystemic shunt performed with expanded-polytetrafluoroethylene 

stent-grafts 

F. Fanelli, F.M. Salvatori, M. Bezzi, P. Nardis, V. Dominelli, E. Boatta, R. Passariello; Rome/IT

Rome 2006 


P221 Evaluation of cost and clinical effectiveness of the Viatorr stent compared to uncovered stents for transjugular intrahepatic 

portosystemic shunt procedures in a tertiary referral centre 

N.D. Forester, J. Rahmen, R. Rushambuza, J.V. Patel, D.O. Kessel, A.A. Nicholson; Leeds/UK 

P222 Digital subtraction pulmonary arteriography versus multidetector computed tomography in the detection of pulmonary 

arteriovenous malformations 

A. Nawaz, S. Trerotola, H. Litt, S. Stavropoulos, S. Charagundla, R. Shlansky-Goldberg, D. Torigian, D. Freiman; 

Philadelphia/US 

P223 Non-invasive visualization of the uterine artery before uterine arterial embolization: usefulness of unenhanced 3D 

sensitivity-encoding water-excitation time-of-flight magnetic resonance-angiography 

K. Mori1, M. Shiigai1, T. Ueda1, M. Minami1, N. Kita2, N. Tanaka2; 1Tsukuba/JP, 2Ushiku/JP 

P224 Prevalence of renal artery stenosis in routine aortofemoral angiography 

U. Özkan, L. Oguzkurt, F. Tercan, S. Ulusan, S. Demir, O. K?z?lk?l?c; Adana/TR 

P225 Fenestrated aberrant hepatic artery 

Y. Takeuchi1, Y. Arai1, H. Morishita2, Y. Inaba3, M. Takahashi1, T. Kobayashi1, R. Iwata1, Y.N. Arai1; 1Tokyo/JP, 2Kyoto/JP, 

3Nagoya/JP 

P226 Alterations in carotid blood flow and endothelial structure in women with polycystic ovarian syndrome: a marker of 

atherosclerotic risk? 

A. Balanika, E. Trakakis, D. Loggitsi, M. Mademli, M. Pektasidi, C. Baltas, E. Alexopoulou, E.N. Brountzos; Athens/GR 

P227 Radiological findings of popliteal entrapment syndrome 

U. Özkan, L. Oguzkurt, F. Tercan, A. Pourbagher, R. Turkoz, O. Gulcan; Adana/TR 

P228 Three-Tesla magnetic resonance angiography with dedicated software and Moby Track in pre-procedural evaluation 

of patients with critical limb ischemia. Preliminary experience 

V. Pipitone, M. Stefanini, S. Fabiano, L. Maresca, C. Reale, R. Gandini, G. Simonetti; Rome/IT 

P229 Intraarterial magnetic resonance-aortography in patients with/without parallel imaging technique 

S. Potthast, A.-C. Schulte, G.M. Bongartz, A.L. Jacob, M. Aschwanden, D. Bilecen; Basel/CH 

P230 Comparison of orbital color-Doppler and magnetic resonance-angiography in the diagnosis of carotid cavernous 

sinus fistulas: personal experience in 20 cases 

M. Venturini, F. D'Ascenzo, S. Bianchi Marzoli, F. Simionato, N. Anzalone, A. Del Maschio; Milan/IT 

P232 Retrievable or permanent: Which caval filter to use? 

A.N. Keeling, S. Looby, A. Geoghegan, M.F. Given, M.J. Lee; Dublin/IE 

P233 Salvage of immature vascular accesses for hemodialysis 

H. Rikimaru, M. Arakawa, K. Abe; Ishinomaki/JP 

P234 Interventional radiology of central venous access: long-term experience in 5000 patients 

G. Giordano, M. Midulla, F. Galli, F. Perona, G. Cornalba; Milan/IT 

P235 Recovery G2 vena cava filter: retrievability study 

V.L. Oliva, G. Soulez, E. Therasse, M.-F. Giroux, P. Perreault, L. Bouchard, N. Denbow; Montreal, PQ/CA 

P236 Endovascular treatment of venous outflow stenoses after orthotopic liver transplantation 

M. Echenagusia Boyra, G.I. Rodríguez Rosales, J. Crespo San Jose, A. Lancharro Zapata, G. Simo Muerza, 

F. Camuñez Alonso; Madrid/ES 

P237 An early experience with the Günther Tulip inferior vena cava filter in gynecologic patients 

K. Myohjin1, J. Koizumi1, T. Hashimoto1, M. Naganuma1, R. Nagashima1, T. Yamashita1, Y. Iwata2, Y. Imai1; 1Isehara/JP, 

2Oiso/JP 

P238 Detection of tilting toward anterior or posterior direction during placement of the Günther Tulip filter in inferior 

vena cava and correction by reposition. A phantom study and preliminary clinical results 

T.-S. Seo, I.-H. Cha, C.M. Park, K.A. Kim, C.H. Lee, J.W. Choi; Seoul/KR 

P239 Withdrawn by author 

P240 Superior vena cava obstruction-2 and 3D multidetector row CT venography and catheter directed therapy 

G.M. Wyse, L.P. Lawler; Baltimore/US 

P241 Treatment of superior vena cava syndrome with T-type vascular stent 

N.K. Chang, J.K. Kim, H.S. Yang, Y.L. Shen; Gwang-ju/KR 

71



P242 Endovenous ablation of the lesser saphenous vein for venous insufficiency and varicose veins: experience with a 

980-nm diode laser system 

S. Ganguli, B. Janne d'Othee; Boston/US 

P243 Treatment of incompetent saphenous veins: a review of available techniques 

B. Janne d'Othee1, J. Koizumi2; 1Boston/US, 2Isehara/JP 

P244 An in-vivo study of an investigational conical shaped retrievable inferior vena cava filter: the Option 

M.C. Proctor; Ann Arbor/US 

P245 Temporary Inferior Vena Cava (IVC) filter retrieval: Preliminary data for complications, retrieval success and failures 

K.J. Nelson, U.C. Turba, A.H. Matsumoto, K.D. Hagspiel, J.F. Angle, M.D. Dake; Charlottesville/US 


P247 Percutaneous computed tomography-guided screw insertion in pelvic fractures 

N. Amoretti1, P. Eude2, E. Hovorka1, J.-N. Bruneton1; 1Nice/FR, 2Aurillac/FR 

P248 Pediatric abdominal visceral trauma: conservative management with intraarterial embolization 

R. Suri, M.H. Wholey, D. Postoak, M.A. Cura; San Antonio/US 

P249 Ultrasonography-guided transthoracic needle biopsy of the chest. Different approaches according to location 

S. Choi; Incheon/KR 

P250 National survey on patient doses in interventional radiology. Design and preliminary results 

E. Vano 1, A. Segarra 2, A. Aspiazu 3, M. Canis 

P251 Treatment of lymphangioma in children using ultrasound-guided injection of OK-432 

R. Nani, R. Agazzi, G. Bonini, A. Tomasoni, D. Vavassori, G. Locatelli, C. Valentino; Bergamo/IT 

P252 Embolization of peripheral vascular malformations with ethylene vinyl alcohol copolymer 

F. Numan, M. Cantasdemir, C. Çaliskan, H. Özer, M. Özbayrak; Istanbul/TR 

P253 Metal airway stents: experience in 36 children 

D.J. Roebuck, C.A. McLaren, M.J. Elliott; London/UK 

P254 Benign tracheobronchial strictures: long-term results and factors affecting airway patency 

after temporary placement of covered retrievable nitinol stents 

J.H. Shin, J.H. Kim, H.-Y. Song, G.-Y. Ko, H.-K. Yoon, K.-B. Sung; Seoul/KR 

P255 Patient and staff radiation doses in vertebroplasty 

E.P. Efstathopoulos 1, N. Fitoussi 2, A.D. Kelekis 1, H. Delis 2, S. Kottou 1, G. Panayiotakis 2, D.A. Kelekis 1; 

1Athens/GR, 2Patras/GR 

P256 Endovascular treatment of visceral aneurysms and pseudoaneurysms 

E. Paci, M. Verdecchia, S. Alborino, R. Candelari, L. Carbonari, E. Antico; Ancona/IT 

P257 Primary aortic stenting in aortoarteritis 

H. Deshmukh, K. Rathod; Mumbai/IN 

P258 Pediatric neuroangiography: technique and review of intracranial pathology with correlative imaging 

A.M. Cahill, R.D. Kaye, K.M. Baskin, R.B. Towbin; Philadelphia/US 

P259 Benefit of intra-articular corticosteroid injection under fluoroscopic guidance for subtalar arthritis 

in juvenile idiopathic arthritis 

A.M. Cahill, R.D. Kaye, K.M. Baskin, T. Beukelman, R. Cron, R.B. Towbin; Philadelphia/US 

P260 A clinical experience with cone-beam computed tomography for non-vascular interventional procedures 

T. Hashimoto, M. Honda, N. Seino, T. Hashizume, H. Shinjo, T. Gokan; Tokyo/JP 

P261 Surface coating of catheters with a biomembrane-like polymer for preventing thrombosis 

T. Hasebe 1, A. Kamijo 1, K. Takahashi 2, K. Goto 2, S. Yohena 2, Y. Takeuchi 2, A. Hotta 2, K. Takahashi 1, T. Suzuki 2; 

1Tokyo/JP, 2Yokohama/JP 

P262 Selective embolization of facial high-flow vascular dysplasia 

I. Kaskarelis, A. Parlamenti, V. Kostaras, E. Iliopoulou, P. Galina, V. Ouranos, N. Papadeogeorgakis, S. Papaspyrou; 

Athens/GR

Rome 2006 


P263 Mistakes, blunders and negligence in the UK - What we can learn from 10 years of complaints. A review of all 

complaints against interventional radiology made to the National Health Service Litigation Authority (NHSLA) 

since its inception in 1995. 

P.O. Cowley, L. Ratnam; London/UK 

P264 Percutaneous intravascular foreign body retrieval: 10 year experience. 

K.J. Nelson, U.C. Turba, A.H. Matsumoto, K.D. Hagspiel, J.F. Angle, M.D. Dake; Charlottesville/US 


73

74 CIRSE 

C RSE

first announcement - CIRSE.org

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?